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The human gut harbours trillions of symbiotic bacteria that play a key role in programming 
different aspects of host physiology in health and disease. These intestinal microbes are also 
key components of the gut-brain axis, the bidirectional communication pathway between the 
gut and the central nervous system (CNS). In addition, the CNS is closely interconnected 
with the endocrine system to regulate many physiological processes. An expanding body of 
evidence is supporting the notion that gut microbiota modifications and/or manipulations may 
also play a crucial role in the manifestation of specific behavioural responses regulated by 
neuroendocrine pathways. In this review, we will focus on how the intestinal microorganisms 
interact with elements of the host neuroendocrine system to modify behaviours relevant to 
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1. Introduction  
Our gut harbours trillions of symbiotic microorganisms that are essential and beneficial not 
only for the regulation of host physiology, but also for the appropriate development of central 
nervous system (CNS) and brain responses (Cryan and O'Mahony, 2011; Dinan and Cryan, 
2013; Qin et al., 2010b). The microbiota-gut-brain axis is a bidirectional pathway through 
which the brain regulates the activity of the gut and vice versa and is critical for homeostasis 
of the host system (De Vadder et al., 2014; Dinan and Cryan, 2017; Holzer et al., 2012; 
Montiel-Castro et al., 2013; Rhee et al., 2009; Sherwin et al., 2017). A number of different 
mechanisms have been proposed in order to explain how the intestinal microbiota might 
influence the brain including the enteric nervous system (ENS: neurons in the intestine), the 
vagus nerve, inflammatory mediators, microbial metabolite production and the 
neuroendocrine system (Dinan et al., 2015; Mayer et al., 2015). Neural-endocrine interactions 
are also critical for regulating behavioural processes in the body in a system of 
neuroendocrine integration. A growing body of evidence is supporting the notion that the 
microorganisms present in the gut might interact with elements of the host neuroendocrine 
system therefore resulting in modifications of the host behaviour. Moreover, the gut 
microbiota produces several hormone-like metabolites that enter the circulation and act at 
distal sites and organs including the brain.  
 
In this review, we will first provide a description of the neuroendocrine system and the 
microbiota-gut-brain axis and will focus on the mechanisms as to how the gut microbiota 
might influence neuroendocrine function. Furthermore, we will analyse the current scientific 
evidence on how the gut microbiota regulates different behavioural phenotypes via 
neuroendocrine integration, as summarised in Table 1. It is important to note that, as the 




to take into consideration the influence of sex differences in neuroendocrine-mediated 
behaviours. The different behavioural outcomes taken into consideration are as follows: 
stress-related behaviour, eating behaviour, sexual behaviour, social behaviour, cognition and 
addiction (Fig.1). These behaviours have been selected for this review because they have 
been shown to be modulated by neuroendocrine routes (Bos et al., 2012; Carter, 1992; Kosten 
and Ambrosio, 2002; McCall and Singer, 2012; McEwen and Sapolsky, 1995; Murray et al., 
2014; Sirinathsinghji, 1987; Smith et al., 2002; Tsigos and Chrousos, 2002b). The manuscript 
is organised in sections where each section corresponds to a behavioural outcome and the 





Table 1. A list of correlations between gut microbiota, hormones and behaviour. 
Host 
Response 
Species Manipulation Details  Reference 
Stress Mouse GF GF mice show hyper-activation of HPA axis in response to restraint stress. Plasma 
ACTH and corticosterone are ↑ in GF compared to SPF mice. GF mice have ↓ BDNF 
expression levels in cortex and hippocampus 
Sudo et al., 
2004 
 
   GF mice have ↓ anxiety-like behaviour and ↑ motor activity compared to SPF mice. GF 
mice also show altered expression of synaptic plasticity-related genes. However, plasma 




   GF mice have ↓ anxiety-like behaviour, ↑ motor activity and ↑ corticosterone levels compared to 
normal mice 
Diaz Heijtz 
et al., 2011 
  FMT in GF Colonization of GF mice with SPF microbiota early in life, but not at a later stage, 
restores the HPA functionality 
Sudo et al., 
2004 
  CS + probiotic administration 2-week treatment with L. helveticus and B. longum attenuates HPA axis response to 




et al., 2014 
  Probiotic administration Chronic treatment with L. rhamnosus ↓ levels of stress-induced corticosterone levels and 
ameliorates anxiety-like behaviours thorugh the vagus nerve 
Bravo et al., 
2011 
  Infection + Probiotic 
administration  
Infection with C. rodentium induces stress-induced memory impairment that is 
prevented by a combination of L. rhamnosus and L. helveticus. Exposure to 
psychological stress ↑ serum corticosterone, which is ↓ by probiotics  
Gareau et 
al., 2011 
  Prebiotic administration  Sialyllactose administration ↓ intestinal microbial dysbiosis and anxiety-like behaviour 
induced by a stressor. This prebiotic, however, does not ↓ corticosterone levels 
Tarr et al., 
2015 
   Chronic treatment with FOS and GOS ↓ stress-induced corticosterone release and 






normalised following treatment 
 Rat MS + probiotic 
administration  
B. infantis normalizes the immune response and behavioural deficits induced by MS but 
no differences in corticosterone concentrations between groups 
Desbonnet 
et al., 2010 
  Maternal probiotic 
administration 
B. animalis and P. jensenii protect against immune dysfunction and disturbance of the 
gut microbiota provoked by MS and/or adult restraint stress. This combination also 
activates neonatal stress pathways (↑ neonatal corticosterone) which persists into 
adulthood (↑ ACTH) 
Barouei et 
al., 2012 
 Human Probiotic administration L. helveticus and B. longum in combination ↓ urinary cortisol levels suggesting an 
attenuation of HPA axis response to stressors 
Messaoudi 
et al., 2011 




MS MS causes a disruption of the gut microbiota and associated stress-like behaviour but 






Mouse  Prebiotic administration +/- 
HFD 
In normal mice, FOS ↓ epididymal fat mass and ↑ plasma GLP-1. In high-fat-fed mice, 
FOS ↓ energy intake, body weight, glycemia and epididymal fat mass 
Delmee et 
al., 2006 
  Prebiotic administration + 
HFD 
β-glucan and inulin ↓ weight gain in high-fat fed mice Arora et al., 
2012 
  Probiotic administration VSL#3 ↓ weight gain and food intake. Glucose tolerance improves. GLP-1 levels ↑ Yadav et 
al., 2013 
  GF GF mice have ↓ total body fat than conventionally raised mice. Recolonization of GF 
mice ↑ body fat content and insulin resistance 
Backhed et 
al., 2004 
   GF mice have ↑ preference of fat intake. Intestinal levels of CCK, PYY and GLP-1 are ↓ Duca et al., 
2012 
 Rat GF Autoantibodies directed against appetite-regulating peptides are ↓ in GF rats compared 
to SPF rats 
Fetissov et 
al., 2008 




are ↓ 2004 
  Probiotic administration Lactobacillus strains ↓ food intake. PYY levels ↑ Forssten et 
al., 2013 
 Human Administration of propionate-
augmenting compound 
Colonic propionate ↓ reward-based eating behaviour. Effect not accompanied by 
alterations in levels of PYY and GLP-1 
Byrne et al., 
2016 
  Prebiotic administration Oligofructose ↑ weight loss and improve glucose toleration in overweight adults. Ghrelin 




   Oligofructose ↑ satiety following breakfast and dinner and ↓ hunger following dinner. 
Mechanisms not fully understood, but it is known that oligofructose ↑ GLP-1 release 
Cani et al., 
2006 
  Probiotic administration L. rhamnosus CGMCC1.3724 ↑ weight loss in obese ♀. Circulating leptin ↓ Sanchez et 
al., 2014 




Rat GF GF rats do not have discriminative urinary odours needed for mating Singh et al., 
1990 
 Locust GF Gut bacteria are responsible for the production of guaiacol, a key component of 
pheromones. Faecal pellets of GF locusts smell different from faecal pellets of normal 
locusts 




Antibiotic administration Symbiotic bacteria influence mating preference by modulating levels of cuticular 






Mouse Antibiotic administration in 
adolescence 
Antibiotic-treated mice have ↓ mRNA expression of oxytocin and vasopressin in the 
hypothalamus, ↓ anxiety, ↓ non-spatial memory and impaired performance in the social 
transmission of food preference test 
Desbonnet 
et al., 2015 
  HFD during pregnancy, 
probiotic administration 
Offspring of high-fat-fed mothers have ↓ oxytocin immunoreactive neurons in the 
hypothalamus accompanied by social behavioural deficits and altered gut microbiome. 
Buffington 








Mouse GF GF mice display absence of non-spatial and working memory. Psychological stress ↑ 
serum corticosterone, which is ↓ by probiotics  
Gareau et 
al., 2011 
  Infection + probiotic 
administration 
C. rodentium causes stress-induced impairment in memory. Pre-treatment of C. 
rodentium-infected mice with a combination of Lactobacillus-containing probiotics 
prevents stress-induced memory deficits and ameliorates serum corticosterone levels 
Gareau et 
al., 2011 
   L. rhamnosus enhances memory to an aversive cue and context and ↓ corticosterone Bravo et al., 
2011 
  Antibiotic administration in 
adolescence 
Antibiotic treatment induces non-spatial memory deficits and ↓ oxytocin mRNA levels 
(in the hypothalamus) 
Desbonnet 
et al., 2015 
Addiction Mouse GF GF mice have ↑ HPA response. As stress is a major risk factor for addiction, this might 
be relevant for addiction 
Sudo et al., 
2004 
   GF mice have ↓ levels of dopamine in the caecum compared to SPF mice. As dopamine 
is a central neurotransmitter involved in reward pathways, this might be relevant for 
addiction 
Asano et al., 
2012 
  Antibiotic administration Antibiotic-treated mice have ↓ mRNA expression of oxytocin in the hypothalamus. 
Given that oxytocin is a key neurotransmitter involved in addiction pathways, this might 
be relevant for addiction 
Desbonnet 
et al., 2015 
   Antibiotic-treated mice have ↑ sensitivity to cocaine reward Kiraly et al., 
2016 
 
Abbreviations: ↑ increase, ↓ decrease, AA arachidonic acid, ACTH adrenocorticotropic hormone, BDNF brain-derived neurotrophic factor, CCK 
cholecystokinin, CS chronic stress, DHA docosahexaenoic acid, FMT faecal microbiota transplantation, FOS fructooligosaccharide, GF germ-
free, GLP-1 glucagon-like peptide-1, GOS galactooligosaccharide, HFD high-fat diet, HPA hypothalamic–pituitary–adrenal axis, MIA maternal 




2. Neuroendocrine System 
The nervous and endocrine systems are intricately connected to each other and are 
responsible for the regulation of various physiological processes in the human body. This 
neuroendocrine system has a crucial role in developmental processes and tissue function, and 
it is composed of the hypothalamus, pituitary gland and target organs. For the scope of this 
review, we will take into consideration four of the six major neuroendocrine pathways: the 
hypothalamic–pituitary–adrenal axis (HPA), the hypothalamic–pituitary–thyroid axis (HPT), 
the hypothalamic–pituitary–gonadal axis (HPG) and the hypothalamic–neurohypophyseal 
axis (HN). Two more pathways, the hypothalamic-pituitary-liver axis and the hypothalamic-
pituitary-prolactin axis, also form the neuroendocrine system but will not be covered in this 
review due to the scarce evidence linking these to the gut microbiota.  
In this section, we will briefly describe the main features of the HPA, HPT, HPG and HN 
axes and function of related hormones. 
 
2.1 Hypothalamic–Pituitary–Adrenal Axis (HPA)  
The HPA axis is one of the main neuroendocrine systems in the human body. In the presence 
of an external stimulus, neuroendocrine neurons in the paraventricular nucleus (PVN) of the 
hypothalamus synthesize and secrete vasopressin and corticotrophin-releasing factor (CRF) 
(Del Rey, 2008). These two peptides stimulate the secretion of adrenocorticotropic hormone 
(ACTH) from the corticotropic cells of the pituitary gland. As a result of ACTH secretion, the 
adrenal cortex produces glucocorticoid hormones: cortisol in humans and corticosterone in 
rodents (Stephens and Wand, 2012). These two hormones in turn act back on the 
hypothalamus and pituitary gland in a negative feedback cycle. The HPA represents the main 
coordinator of stress response, but it also regulates other body processes such as digestion, 




threat is perceived, the HPA axis mounts a defensive response and restores the homeostatic 
balance in the organism (de Kloet et al., 2005; Frodl and O'Keane, 2013; McEwen, 2007; 
Sapolsky, 1996). The activation of the HPA axis ultimately results in the release of 
behaviour-altering glucocorticoids, mineralocorticoids and catecholamines (Smith and Vale, 
2006a; Tsigos and Chrousos, 2002a). The activity of the HPA axis is regulated by several 
afferent sympathetic, parasympathetic, and limbic circuits (e.g. amygdala, hippocampus, and 
prefrontal cortex) innervating either directly or indirectly the PVN (Smith and Vale, 2006a). 
Interestingly, under physiological conditions the HPA axis has a continuous oscillatory 
activity synchronized with circadian and ultradian rhythms (Dallman et al., 1994; Dickmeis et 
al., 2013; Tsigos and Chrousos, 2002a). In the presence of a stressful stimulus, 
glucocorticoids enter the brain and bind to the mineralocorticoid receptors and glucocorticoid 
receptors. Receptors sensitive to glucocorticoids are expressed throughout the CNS including 
in the same brain regions involved in the mounting of a stress-mediated neuroendocrine 
response (Sapolsky et al., 1984). Interestingly, the HPA has been shown to interact with both 
the immune system (Leonard, 2005) and the gonadal axis (Viau, 2002). In the early 1990s, it 
became apparent that cytokines and other humoral mediators of inflammation are strong 
activators of the central stress response, forming the afferent branch of a feedback loop 
through which the immune/inflammatory system and the CNS communicate (Chrousos, 
1995). For instance, the three inflammatory cytokines tumor necrosis factor-α (TNF-α), 
interleukin-1β (IL-1β) and interleukin-6 (IL-6) are known to activate the HPA axis (Chrousos 
1995; Tsigos, 1997). Moreover, components of the HPA axis can inhibit the gonadal system, 
indeed CRF is able to suppress the GnRH (gonadotropin-releasing hormone) neurons of the 
hypothalamus (see section 2.3) (Chrousos et al., 1998). 
 




The HPT axis is one of the central regulators of metabolism in the human body. When the 
hypothalamus senses low circulating levels of thyroid hormones [triiodothyronine (T3) and 
thyroxine (T4)], it releases thyrotropin-releasing hormone (TRH). The TRH acts on the 
pituitary gland and stimulates thyrotropic cells to produce thyroid-stimulating hormone 
(TSH). The TSH, in turn, stimulates the thyroid to produce T3 and T4 until levels in the blood 
return to normal (Zoeller et al., 2007). The major portion of T3, however, is produced in 
peripheral organs such as liver, adipose tissue, glia and skeletal muscle by deiodination of 
circulating T4. The deiodination process is controlled by several hormones and 
neurotransmitters including TSH, vasopressin and catecholamines (Mariotti and Beck-
Peccoz, 2000). Thyroid hormones regulate the hypothalamus and the anterior pituitary gland 
via a negative feedback loop. They also directly affect metabolism, cardiovascular system 
and development. For instance, T3 and T4 are able to increase the basal metabolic rate and 
induce effects on almost all body tissues (Hall, 2011). Moreover, they influence appetite, 
absorption of substances (especially glucose) and gut motility. Thyroid hormones stimulate 
the breakdown of fats and also decrease cholesterol levels, by increasing the rate of secretion 
of cholesterol in bile (Hall, 2011). The cardiovascular effects of thyroid hormones include an 
increase in the rate and strength of the heartbeat, an increase in oxygen consumption, and an 
increase the activity of mitochondria (Hall, 2011). Finally, thyroid hormones have been 
proven to be essential for brain maturation and brain function throughout life (Bernal, 2000). 
Indeed, thyroid diseases in adults can lead to several clinical manifestations (Joffe and 
Sokolov, 1994). Thyroid hormones function by crossing the cell membrane and binding to 
intracellular receptors called ‘thyroid hormone receptors’ (TR; e.g. TR-α1, TR-α2, TR-β1, 
TR-β2). These receptors, together with corepressor molecules, bind DNA regions termed 
‘thyroid hormone response elements’ (TREs) localised near genes and modulate gene 





2.3 Hypothalamic–Pituitary–Gonadal Axis (HPG) 
The HPG axis comprises of the hypothalamus, pituitary gland, and gonadal glands. This 
neuroendocrine axis plays a critical part in the development and regulation of different body 
processes, mainly the reproductive and immune systems (Corradi et al., 2016). Variations in 
this system can result in altered hormone production by the ovaries/testes resulting in 
different local and systemic effects. The hypothalamus secretes gonadotropin-releasing 
hormone (GnRH) and, as a result of that, gonadotropic cells from the anterior pituitary gland 
produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH 
send signals to the gonads and trigger testosterone and estrogen production in the testes and 
ovaries. One of the most important functions of the HPG axis in females is to regulate 
reproduction by controlling the uterine and ovarian cycles (Plant, 2015). In females, the 
positive feedback between estrogen and LH helps to prepare the follicle in the ovary and the 
uterus for ovulation and implantation. Moreover, the activation of the HPG axis in both males 
and females during puberty induces individuals to acquire secondary sex features (Plant, 
2015). In males, FSH and LH stimulate the production of testosterone, a hormone required 
for normal spermatogenesis (Huang et al., 2001; Walker and Cheng, 2005). At birth, FSH and 
LH levels are elevated with females having a lifetime supply of primary oocytes. High levels 
of estrogen and testosterone released from testes and ovaries inhibit the production of GnRH 
from the hypothalamus through a negative-feedback loop (Whirledge and Cidlowski, 2010). 
Moreover, sex steroids are also known to modulate brain function, development and 
behaviour (Vadakkadath Meethal and Atwood, 2005). Testosterone levels, for example, have 
been shown to relate to prosocial behaviour (Wibral et al., 2012). As mentioned in section 
2.1, the HPG is also connected and influenced by the HPA axis (Viau, 2002).  
 




The posterior pituitary (or neurohypophysis) comprises a collection of axonal projections 
coming from the hypothalamus which secretes the hormones oxytocin and vasopressin into 
the neurohypophyseal capillaries, from where they reach the systemic circulation (Phelps, 
2007). In addition to axons, the posterior pituitary also contains pituicytes, specialized glial 
cells assisting in the storage and release of the hormones (Hatton, 1988).  
Oxytocin is a peptide hormone that has both peripheral and central action, which is mediated 
by specific oxytocin G-protein-coupled receptors. This hormone is crucial for stimulation of 
milk ejection, uterine contractions during labour and plays a key role in several behaviours 
including social recognition, pair bonding, anxiety and maternal behaviours (White BA, 
2013). Oxytocin is a key mediator of social bonding (Carter et al., 1992). In humans oxytocin 
has been linked to parental behaviour and parent-infant bonding. For example, high 
endogenous oxytocin levels peri-partum are associated with increased mother-infant bonding 
(Feldman et al., 2007). Especially because of its role in mediating social behaviours, oxytocin 
has been implicated in the aetiology of autism (Jacob et al., 2007; Wermter et al., 2010). 
Finally, a large body of evidence links oxytocin to stress regulation. In rodents, peripheral 
and central oxytocin levels have been found to increase in response to a wide variety of 
stressful stimuli, such as conditioned fear stimuli and restraint stress (Neumann et al., 2000; 
Onaka, 2004). In humans, an increase in plasma oxytocin was found in response to several 
types of psychosocial stressors (Hoge et al., 2008; Marazziti et al., 2006; Taylor et al., 2010). 
Moreover, oxytocin administration in humans was able to decrease the subjective stress 
ratings (Heinrichs et al., 2003) as well as increase the parasympathetic cardiac control 
(Norman et al., 2011) and decrease the salivary cortisol levels (Ditzen et al., 2009; Linnen et 
al., 2012). Given the beneficial roles of oxytocin in social bonding and stress regulation, this 





Vasopressin is responsible for the regulation of the body’s water retention. When the body is 
dehydrated, vasopressin is released from axon terminals in the posterior pituitary and causes 
the kidneys to conserve water, thus concentrating the urine and reducing urine volume (Sands 
et al., 2011). In addition to this peripheral function, vasopressin in the brain acts in 
conjunction with CRF to modulate the release of corticosteroids from the adrenal gland in 
response to stress, particularly during pregnancy and lactation in mammals (Goland et al., 
1991; Ma et al., 2005; Toufexis et al., 1999).  
 
3. Gut Microbiota 
As stated earlier our gut houses a staggering amount of microorganisms that estimates 
consider contains 150 times as many genes as our genome (Qin et al., 2010a). This 
population is mainly composed of bacteria belonging to 500-1000 different species (Qin et 
al., 2010a). Fungi, archaea, and viruses are also present in the gut but less is known about 
their underlying functions. The intestinal microbiota does not remain stable throughout 
lifespan, in fact the microbiota of newborn infants, acquired at delivery, is characterised by 
low diversity and a relative dominance of the phyla Proteobacteria and Actinobacteria 
(Kurokawa et al., 2007). The microbial composition of the neonatal gut is influenced by a 
number of factors including antibiotic use, diet, mode of delivery, environmental factors and 
the maternal microbiota (Dominguez-Bello et al., 2010; Faa et al., 2013; Koenig et al., 2011; 
Marques et al., 2010). Interestingly, the microbiota of formula-fed infants is significantly 
different from the microbiota of breastfed infants (Bezirtzoglou et al., 2011; Lee et al., 2015; 
Wang et al., 2015). Moreover, vaginally delivered infants acquire the vaginal microbiota of 
the mother, whereas infants delivered by caesarean section are colonised by other 
environmental sources (Dominguez-Bello et al., 2010). In the first months of life, the number 
of strict anaerobes such as Clostridium, Bacteroides and bifidobacteria increases gradually 




more stable over time and more complex than the neonate microbiota (Hamady and Knight, 
2009).  
 
4. Microbiota-Gut-Brain Axis 
The microbiota-gut-brain axis is a bidirectional pathway through which the brain regulates 
the activity of the gut and vice versa. This bidirectional axis functions through a series of 
different routes (Bercik et al., 2012; Dinan et al., 2015; Rhee et al., 2009) and comprises an 
afferent and an efferent pathway. 
 
4.1 Afferent Signalling 
The vagus nerve, the tenth cranial nerve that has both efferent and afferent divisions, is a 
major modulatory constitutive communication pathway between the bacteria exposed to the 
gut and the brain (Bercik et al., 2011b; Bravo et al., 2011). The immune system provides a 
further route of communication between gut microbes and the brain, in fact microbiota and 
probiotics have a direct effect on the immune system (Duerkop et al., 2009b; Forsythe and 
Bienenstock, 2010). Symbiotic bacteria are crucial for the maturation of the immune system 
in fact, they provide signals for the development of key lymphocyte subsets (Edelman and 
Kasper, 2008). Moreover, gut bacteria contribute to intestinal epithelial cell maturation and 
can induce alterations in the circulating levels of pro- and anti-inflammatory cytokines that 
directly affect brain function, especially areas such as the hypothalamus, where IL-1 and IL-6 
provide a potent release of CRF (Duerkop et al., 2009a). Gut bacteria contribute to the host 
metabolism by production of metabolites such as bile acids, choline and short chain fatty 
acids (SCFAs, namely acetic propionic and butyric acid) that are able to influence a range of 
physiological and metabolic functions (De Vadder et al., 2014). The free SCFAs are also able 
to cross the blood-brain barrier (BBB) through monocarboxylate transporters and act in 




microbiota can produce neuropeptide-like compounds, it is capable of generating a number of 
neurotransmitters and neuromodulators (Cryan and Dinan, 2012; Nicholson et al., 2012). 
Members of the genera Candida, Streptococcus, Escherichia and Enterococcus synthesize 5-
hydroxytryptamine (5-HT); members of the genera Escherichia, Bacillus and Saccharomyces 
generate dopamine and/or noradrenaline; members of the genus Lactobacillus produce 
acetylcholine; and members of the genera Lactobacillus and Bifidobacterium produce 
gamma-aminobutyric acid (GABA) (Barrett et al., 2012; Cryan and Dinan, 2012; Lyte, 2014; 
Nicholson et al., 2012; Wall et al., 2014). An example of the connection of the gut 
microbiome with the host neurophysiological systems is a study showing that the excitability 
of gut sensory neurons located within the myenteric plexus of the ENS relies on the presence 
of the normal commensal microbiota for proper functioning (Neufeld et al., 2011). Several 
studies have suggested that another mechanism involved in the gut-brain communication is 
tryptophan metabolism. Tryptophan is an essential amino acid and is a precursor to many 
biologically active agents, such as serotonin (Ruddick et al., 2006). Most of the tryptophan is 
metabolised to kynurenine and the disruption of this metabolic pathway has been linked to 
both gastrointestinal and brain disorders (Fitzgerald et al., 2008). The first rate-limiting step 
in the kynurenine metabolic cascade is catalysed by some enzymes (specifically indoleamine-
2,3-dioxygenase and tryptophan 2,3-dioxygenase) whose activity can be induced by 
inflammatory mediators and by corticosteroids, respectively (Ruddick et al., 2006). Evidence 
suggests that a probiotic bacterium, Bifidobacterium infantis, can alter concentrations of 
kynurenine through modulation of the gut microbiota (Desbonnet et al., 2008). Another class 
of molecules, gut-derived peptides, can reach the systemic circulation and bind receptors on 
immune cells and vagus nerve terminals thereby enabling indirect gut-brain communication 
(Lach et al., 2017). 
 




The HPA axis represents the main efferent route from the brain to the gut. When activated, 
the resulting secretion of cortisol (in humans) or corticosterone (in rodents) affects immune 
cell activity; both locally in the gut and systemically (Del Rey, 2008). Neuronal efferent 
activation includes also the efferent branch of the vagus nerve that, when activated induces a 
release of acetylcholine which, in turn, affect the levels of cytokines (Paton et al., 1971). 
 
Some of the key communication routes of the gut-brain axis are thought to be responsible for 
the communication between the gut microbiota and neuroendocrine function and will be 
examined exhaustively in the following chapter.  
 
5. How does Gut Microbiota affect Neuroendocrine Function? 
The mechanisms through which the gut microbiota might influence neuroendocrine function 
and consequently host behaviour have not yet been fully deciphered. However, increasing 
evidence suggests that the gut microbiota acts through direct production of neuroendocrine 
metabolites (hormone-like metabolites such as SCFAs, neurotransmitters, GI hormones, 
precursors to neuroactive compounds such as tryptophan & kynurenine) and, indirectly, as 
modulator of inflammatory responses, immune responses and hormonal secretion (Fig. 2). 
 
In this section, we will describe different mechanisms as to how the gut microbiota modulates 
neuroendocrine function.  
 
 
5.1 Short Chain Fatty Acids 
Butyric, propionic and acetic acids are the main short chain fatty acids (SCFAs) produced by 
bacterial fermentation of proteins and carbohydrates in the intestine (Macfarlane and 




(Cummings, 1981). SCFAs act as direct mediators between the gut and the brain in fact they 
circulate far from their production site and are carried by monocarboxylate transporters, 
which are expressed also on the blood-brain barrier (BBB) (Kekuda et al., 2013; Nisha Vijay, 
2015). Among the SCFAs, propionic acid is able to activate the FFAR3 (free fatty acid 
receptor 3) and exerts beneficial effects on body weight control and glucose metabolism (De 
Vadder et al., 2014). Increasing evidence is suggesting that SCFAs can directly affect brain 
function and behaviour. Interestingly, both butyric and propionic acid affect dopamine and 
noradrenaline synthesis via increase of tyrosine hydroxylase gene expression (DeCastro et al., 
2005; Nankova et al., 2014; Stilling et al., 2016). Furthermore, propionic acid has also been 
shown to modulate serotonergic neurotransmission (Nankova et al., 2014) and lower levels of 
GABA, serotonin and dopamine in vivo (El-Ansary et al., 2012). The ability of SCFAs to 
directly influence neurotransmitters’ synthesis and to inhibit the histone deacetylases may be 
responsible for their behavioural effects (Donohoe et al., 2012; Matis et al., 2013). In fact, 
one of the most recognised cellular mechanism of action of butyrate is its ability to inhibit the 
histone deacetylases (Kruh, 1982). Indeed, when administered systemically, sodium butyrate 
induced a transient histone acetylation in the frontal cortex and hippocampus, resulting in an 
antidepressant-like behaviour (Schroeder et al., 2007). Intriguingly, gut-derived SCFAs have 
also been shown to affect the maturation and function of microglia, the resident macrophages 
of the central nervous system (CNS) (Erny et al., 2015; Huuskonen et al., 2004). Thus, germ-
free mice (born and raised in a sterile environment) display global deficits in microglia with 
altered cell proportions and an immature phenotype; while mice deficient for the SCFA 
receptor FFAR2 do not present alterations in microglia cell densities but have malformed 
microglia, with alterations in dendrite length, number of segments and cell volumes (Erny et 
al., 2015). Interestingly, long-term SCFAs treatment was able to reverse the microglia deficits 
present in germ-free mice (Erny et al., 2015). Similarly, dietary modulation of SCFAs was 




microglia are crucial for the shaping of neural circuits in the developing brain (Bilimoria and 
Stevens, 2015), gut-derived SCFAs might have some relevance in circuits regulating the CNS 
and hypothalamic function. Importantly, SCFAs are also directly implicated in the release of 
hormones and neuropeptides, such as glucagon-like peptide 1 (GLP-1) and peptide YY 
(PYY) from intestinal enteroendocrine cells (Rooks and Garrett, 2016), all of which we will 
discuss in Section 5.3.  
 
5.2 Neurotransmitters and Tryptophan Metabolism 
The gut microbiota produces different neurotransmitters such as dopamine, noradrenaline and 
ɣ-aminobutyric acid (GABA) (Roshchina, 2016) that can enter the circulation and potentially 
reach distal sites. Neurotransmitters influence hypothalamic function and the major 
neuroendocrine axes in the host, therefore the gut-mediated production/regulation of these 
neurotransmitters may play a crucial role in neuroendocrine function. Noradrenaline (NA) 
and dopamine (DA) are two crucial neurotransmitters that regulate many physiological 
processes in the brain and the body. Levels of both the neurotransmitters have been shown to 
be reduced in the caecum of germ-free mice compared to the SPF mice (Asano et al., 2012), 
which suggests that the gut microbiota is a potential source of catecholamines. These results 
suggest that there might be a correlation between intestinal bacteria and dopamine levels in 
conditions such as Parkinson’s disease, characterized by insufficient dopamine production in 
the brain. Moreover, Helicobacter pylori has been shown to affect L-DOPA levels 
(Pierantozzi et al., 2006) and neurologic improvement has also been reported in one patient 
with Parkinson's disease after faecal transplantation for chronic constipation (Ananthaswamy, 
2011). However, it is unlikely that these microbial-derived catecholamines have any effect at 
a central level, as they are not able to cross the BBB (blood-brain barrier). Nevertheless, the 
microbiota also appear to be able to modulate central catecholaminergic neurotransmission. 




tyrosine (the rate-limiting substrate for NA and DA synthesis) in comparison with ex-germ-
free animals. This induced a greater level of DA in the brains of GF mice, suggesting that the 
gut microbiota is able to modulate the central levels of catecholamines (Matsumoto et al., 
2013). Another study from Nishino and colleagues also confirmed the same (Nishino et al., 
2013). 
Some intestinal bacteria are also able to produce ɣ-aminobutyric acid (GABA), the main 
inhibitory neurotransmitter in the CNS that is also associated to pathological scenarios such 
as depression and anxiety (Mohler, 2012). Human intestinally-derived strains of 
Lactobacillus and Bifidobacterium have been shown to produce GABA, with L. brevis and B. 
dentium being the most efficient GABA producers among the strains tested (Barrett et al., 
2012). GABA transporters are localized on the blood-brain barrier (BBB) and allow gut-
derived GABA to reach the CNS (Takanaga et al., 2001). Moreover, administration of L. 
rhamnosus to mice altered the expression of GABA receptors in different brain regions, 
resulting in a decrease of anxiety- and depressive-like behaviour (Bravo et al., 2011). 
Whether the peripherally derived GABA is capable of crossing the BBB either through 
diffusion or through active transport remains a matter of dispute (Boonstra et al., 2015). 
According to Takanaga and colleagues (Takanaga et al., 2001), GABA transporters are 
expressed at the BBB and this might be a mechanism through which microbial-derived 
GABA reaches the brain. 
Interestingly, some intestinal microbes are able to metabolise tryptophan, the precursor of 
serotonin (5-HT), an important neurotransmitter involved in adaptive responses of the CNS. 
The first direct effect of microbiota on 5-HT was demonstrated in germ-free mice, which 
have lower plasma levels of this neurotransmitter than conventional mice (Clarke et al., 2013; 
Wikoff et al., 2009). This might be due to reduction in the expression of tryptophan 
hydroxylase, the rate-limiting enzyme in 5-HT synthesis (Yano et al., 2015). Interestingly, 




levels and serotonin turnover in the hippocampus in a sex-dependent manner. Indeed, this 
effect was seen only in male germ-free mice, suggesting that the oestrous cycle might have 
affected the serotonergic system (Clarke et al., 2013). We have shown that chronic 
administration of B. infantis in rats was able to increase the plasma tryptophan levels and 
decrease the kynurenine-to-tryptophan ratio, suggesting a reduced activity of IDO in the 
probiotic-treated rats (Desbonnet et al., 2008). Moreover, the administration of Lactobacillus 
johnsonii in rats has been shown to lower circulating kynurenine levels with concomitant 
increase in serotonin levels (Valladares et al., 2013). Also Streptococcus, Enterococcus and 
Escherichia are able to produce 5-HT (Roshchina, 2016). Interestingly, data from our 
laboratory have shown that faecal microbiota transplantation from depressed patients into 
healthy rats caused a dysregulation in tryptophan metabolism as indicated by increased 
plasma kynurenine-to-tryptophan ratio (Kelly et al., 2016). In addition, the transplanted rats 
showed a significant increase in both circulating and central kynurenine metabolite levels, 
which were similar to levels reported in autism, schizophrenia, depression and 
neurodegenerative diseases (McFarlane et al., 2008; Schwarcz et al., 2012). 
In the context of microbiota-derived neurotransmitters and brain function, there still is much 
work needed to tease apart the relative contribution of alterations in peripheral levels of such 
neurotransmitters either directly or indirectly on neuroendocrine function. 
 
5.3 Enteroendocrine Signalling 
Enteroendocrine cells (EECs) are broadly distributed throughout the gastrointestinal tract and 
exert regulatory effects on the bidirectional communication between the gut and the brain. 
EEC secretory products are released in response to diverse stimuli and influence a variety of 
physiological functions in the host such as control of intestinal secretion and motility, 
regulation of food intake and metabolism (Rehfeld, 2004). Hormones and peptides secreted 




brain, specifically the nucleus tractus solitarii (NTS) (Raybould, 2010b). The main hormones 
secreted by EECs are cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 
(GLP-1). CCK and PYY are mainly secreted in response to fat and proteins ingestion, while 
GLP-1 is secreted after intake of carbohydrates and fats (Cummings and Overduin, 2007). 
Interestingly, there is a body of evidence suggesting that intestinal microbes modulate the 
secretion of these hormones, either directly or indirectly through production of SCFAs. 
Germ-free mice, have alterations in the number of EECs and lower levels of PYY, GLP-1 
and CCK compared to conventionally colonized mice (Duca et al., 2012). Moreover, 
intestinal infusion of E. coli proteins was able to increase plasma PYY and GLP-1 levels 
enhancing satiety (Breton et al., 2016). Breton and colleagues have also suggested that 
caseinolytic protease B (ClpB), a protein produced by E. coli, might be responsible for the 
elevated secretion of satiety peptides from EECs. Finally, short chain fatty acids (SCFAs), 
whose production is in part mediated by intestinal microbes, bind to their receptors (FFAR1 
and FFAR3) expressed on EECs and stimulate the secretion of peptides/hormones (Bellono et 
al., 2017; Nohr et al., 2013; Swartz et al., 2012).  
 
5.4 Immune Signalling 
The contribution of the gut microbiota as stimulator of the immune system is being widely 
investigated. Lipopolysaccharide (LPS), a constituent of the outer membrane of Gram-
negative bacteria and activator of the Toll-like receptor 4 (TLR4), has been suggested to 
cross the intestinal epithelial barrier in response to certain conditions such as stress (Maes et 
al., 2008) or a high-fat diet (Cani et al., 2008; Moreira et al., 2012), leading to immune and 
HPA axis activation. Interestingly, while LPS is able to acutely activate the immune system 
and HPA axis, exposure of newborn rodents to these factors is able to induce long-lasting 
effects. Some evidence showed that neonatal exposure to LPS leads to elevated ACTH and 




in adulthood (Shanks et al., 1995). Concordantly, neonatal LPS exposure decreases cerebral 
glucocorticoid-receptor density, whereas CRF expression is increased (Shanks et al., 1995). 
Moreover, neonatal exposure to LPS induces enhanced prostaglandin-mediated HPA axis 
reactivity to LPS in adulthood (Mouihate et al., 2010).  
 
5.5 Vagus Nerve 
The vagus nerve has received much attention as a conduit of signals from the gut to the brain 
and vice versa (Goehler et al., 2000; Goehler et al., 1999; Goehler et al., 2005). Intestinal 
microbes are able to interact with the CNS through the vagus nerve and control the 
production and/or release of neurotransmitters (Sivamaruthi et al., 2015). The neurochemical 
and behavioural effects of Lactobacillus rhamnosus administration were absent in 
vagotomised mice, identifying the vagus as a major modulatory pathway between gut 
bacteria and the brain (Bravo et al., 2011). Interestingly another probiotic, L. reuteri, was 
shown to enhance wound healing in mice by increasing central levels of oxytocin through a 
vagal pathway (Poutahidis et al., 2013), strengthening the concept that this nerve directly 
links the gut to the hypothalamic-neurohypophyseal axis. Moreover, transient inactivation of 
the dorsal vagal complex was shown to decrease social deficits that were induced by LPS 
administration (Marvel et al., 2004). Vagal afferent signaling has also been implicated in the 
modulation of emotional behaviour, anxiety and fear. For example, a reduced anxiety-like 
behaviour was shown in rats that underwent subdiaphragmatic vagal deafferentation and this 
was associated with region-dependent changes in noradrenaline and ɣ-aminobutyric acid 
(GABA) levels in key areas of the limbic system, but not with functional alterations in the 
HPA axis (Klarer et al., 2014). In addition to this, the anxiolytic effect of Bifidobacterium 
longum was blocked by vagotomy (Bercik et al., 2011b). However, when oral antimicrobials 
were administered to SPF mice, consequent changes in microbiota composition and anxiety-




important function played by the vagus nerve in the context of gut microbiota and endocrine 
function is its role as conduit of signals. As mentioned in Section 5.3, hormones and peptides 
secreted by EECs activate vagal afferent pathways (Bonaz et al., 2018; Maniscalco and 
Rinaman, 2018; Raybould, 2010b) however, it is unclear how the brain might “decipher” the 





6. Gut Microbiota and Stress  
The first scientific publication on “general adaptation syndrome”, or as we know today 
“biologic stress” has been published in Nature in 1936 by the 29-year old Hans Selye. Selye 
described stress as a nonspecific and predictable response of the body to demands placed 
upon it (Szabo et al., 2017). Stress is a condition in which the homeostasis of an organism is 
disturbed by a threat that might be real or perceived (De Kloet et al., 1994; McEwen et al., 
2015). While fear is the physiological response to a real threat, anxiety is an overreaction to a 
situation that is only subjectively perceived as menacing and is characterized by 
disproportionate feelings of fear (Sylvers et al., 2011). When anxiety becomes so 
overwhelming that normal daily functioning is impeded, it can be diagnosed as psychiatric 
disorder. Once a stressful stimulus is perceived and the homeostasis disturbed, an organism is 
able to restore its steadiness through the activation of the HPA axis and sympathetic-
adrenomedullary axis, which ultimately induces the release of behaviour-altering hormones 
such as glucocorticoids, mineralcorticoids and catecholamines (Kudielka et al., 2004; Smith 
and Vale, 2006a). The gut microbiota mediates the production of immune mediators such as 
TNF-α, IL-1β and IL-6 that, in turn, reach the brain and stimulate the HPA axis (Fig.3). 
Moreover, the gut microbiota is able to directly influence the production of glucocorticoid 
hormones (Mukherji et al., 2013). Mukherji and colleagues have shown that the interaction 
between bacterial products and Toll-like receptors (TLR) expressed on the intestinal 
epithelium is crucial for maintaining homeostatic levels of corticosterone, in fact microbiota-
depleted mice have exaggerated and sustained synthesis of corticosterone throughout the day 
(Mukherji et al., 2013). From a behavioural point of view, different stressors are able to 
evoke in the host the so-called fight-or-flight response (Jansen et al., 1995).   
 
The activity of the HPA axis is regulated by multiple afferent sympathetic, parasympathetic, 




either directly or indirectly the paraventricular nucleus (PVN) of the hypothalamus (Smith 
and Vale, 2006b). In response to stress, the sympathetic nervous system (SNS) increases the 
release of catecholamines into systemic circulation, while CRF is released from 
paraventricular neurons of the hypothalamus, which then stimulate the activation of the HPA 
axis ultimately resulting in a release of glucocorticoids from the adrenal cortex. 
Glucocorticoids ultimately reach the brain and mediate their effects through high affinity 
mineralocorticoid receptors and lower affinity glucocorticoid receptors, the latter being 
activated at higher stress intensity (Herman et al., 2016).  
It has been shown that different types of psychological stressors including maternal 
separation, chronic social defeat, physical restraint and overcrowding can alter the gut 
microbiota composition (Bailey, 2014; Bailey et al., 2011; Bharwani et al., 2016; De Palma et 
al., 2015; De Palma et al., 2014; Hsiao et al., 2013; Moloney et al., 2014). The milestone 
paper by Sudo and colleagues was instrumental in linking a role for the gut microbiota in 
stress responses. In this study, germ-free mice exhibited altered HPA axis function, with 
elevated levels of plasma adrenocorticotropic hormone (ACTH) and corticosterone in 
comparison with specific pathogen free (SPF) mice in response to restraint stress (Sudo et al., 
2004). Germ-free mice also had reduced brain-derived neurotrophic factor (BDNF) 
expression levels in the cortex and hippocampus when compared to SPF mice. Moreover, the 
recolonisation of germ-free mice with SPF microbiota early in life, but not at a later stage, 
was able to restore the HPA axis functionality. This suggests that there are functional 
windows when the exposure to indigenous microbiota is required for normal development of 
the HPA axis (Sudo et al., 2004). Several other studies have confirmed that germ-free 
animals have high levels of ACTH and corticosterone following a stressful stimulus (Clarke 
et al., 2013; Crumeyrolle-Arias et al., 2014; Neufeld et al., 2011; Sudo et al., 2004). In the 
absence of a stressful stimulus, germ-free mice display an anxiolytic-like phenotype. Indeed, 




mice with a normal gut microbiota (Diaz Heijtz et al., 2011). Around the same time, Neufeld 
and colleagues showed that germ-free mice have reduced anxiety-like behaviour compared to 
SPF (specific-pathogen free) animals, however, plasma corticosterone levels were higher in 
GF than SPF mice, possibly indicating a stress response in GF mice to experimental 
conditions (Neufeld et al., 2011). Of note, not only have gut microbiota changes been linked 
to alterations in the stress response, but also the opposite scenario has been demonstrated 
(Foster et al., 2017). Indeed this concept is far from new, over 40 years ago Tannock and 
Savage published a pivotal experiment demonstrating the influence of stressful conditions on 
intestinal microbial populations in mice (Tannock and Savage, 1974). Interestingly, Guo and 
colleagues have shown that exposure of mice to psychosocial stress induced an increase of 
Helicobacter pylori colonization in the gastric mucosa that was accompanied by increased 
serum corticosterone levels. In the same study, mice that underwent treatment with a 
glucocorticoid-receptor antagonist (to antagonize the effect of endogenous corticosterone) 
showed decreased colonization by H. pylori (Guo et al., 2009), corroborating the crucial role 
played by glucocorticoids. One animal paradigm that is often used to investigate the effects 
of early life stress exposure in rodents is the maternal separation model, which has been 
shown to induce long-term changes in behaviour, HPA axis activity and alterations of the 
intestinal microbiota diversity/complexity (Lehmann et al., 2002; O'Mahony et al., 2011; 
Plotsky et al., 2005). When comparing maternally separated (MS) to non-separated (NS) rats, 
we have shown that MS animals had marked population-based alterations in the faecal 
microbiota (O'Mahony et al., 2009). Such results are in line with previous work from Bailey 
and Coe that demonstrated that maternal separation in infant rhesus monkeys caused a 
disruption of the gut microbiota integrity (Bailey and Coe, 1999). In addition, these changes 
in the microbiota were correlated with the display of stress-like behaviours, but not with 
cortisol secretion. More recently, we showed that MS rats exhibit a robust depressive-like 




brain, and increased peripheral interleukin-6 release. Moreover, the administration of the 
probiotic B. infantis resulted in normalisation of the behavioural deficits and restoration of 
basal noradrenaline levels in the brainstem, however, there were no differences in 
corticosterone concentrations between groups (Desbonnet et al., 2008; Desbonnet et al., 
2010). Interestingly, it has been demonstrated that maternal probiotic administration 
(Bifidobacterium animalis subsp. lactis and Propionibacterium jensenii) activated neonatal 
stress pathways (with increased neonatal corticosterone levels) which persisted into 
adulthood (with elevated levels of adult ACTH); but it also protected against immune 
dysfunction and to some extent against disturbance of the gut microbiota provoked by MS 
and/or adult restraint stress (Barouei et al., 2012).  
 
In addition to neonatal stress, prenatal stress (PNS) also has powerful and enduring effects on 
behaviour (Beijers et al., 2010; Frye and Wawrzycki, 2003; Maccari et al., 2003; Morley-
Fletcher et al., 2003). In our laboratory we recently demonstrated that chronic PNS in rats 
resulted in hyperactivity of the HPA axis and affected neurodevelopment and functionality of 
the gastrointestinal tract (Golubeva et al., 2015). Interestingly, PNS also induced long lasting 
alterations in the gut microbiota composition, with a strong trend towards decreased numbers 
of bacteria of the Lactobacillus genus. Strikingly, the relative abundance of specific bacteria 
genera significantly correlated with the responsiveness of the HPA axis to stress (Golubeva et 
al., 2015). In line with previous results, Bailey and colleagues have shown that moderate 
disturbance (PNS using an acoustical startle paradigm for 6 weeks) of female monkeys 
during pregnancy was sufficient to alter the intestinal microbiota in the newborn infants 
(Bailey et al., 2004). Other studies have shown that exposure to a stressor can alter the 
microbial community of the gastrointestinal tract (Bailey et al., 2011; Bailey et al., 2010). 
Interestingly, Bailey et al. have shown that the exposure to a prolonged stressor not only 




enteric pathogen Citrobacter rodentium (Bailey et al., 2010). Alterations in gut microbiota 
composition, accompanied by an increased anxiety-like behaviour and cognitive deficits, 
were found in adult female offspring of PNS-exposed dams (Gur et al., 2017). In a 
population-based study, maternal PNS was positively correlated with the infants' microbiota 
composition (Zijlmans et al., 2015), reinforcing the idea that PNS can affect microbial 
composition. Finally, it was recently shown that PNS alters the offspring microbiome in a 
sex-specific manner (Jašarević et al., 2017). 
 
To better investigate the link between gut microbiota and stress-like behaviour, different 
strategies have been applied and include the use of probiotics, prebiotics and antibiotics. 
Probiotics are defined as living micro-organisms that, if administered in adequate amount, 
confer health benefits to the host (Butel, 2014). A combination of Lactobacillus helveticus 
and B. longum to both rats and humans resulted in an anxiolytic-like effect in rats and the 
probiotic combination reduced urinary cortisol levels 24 hours following administration in 
humans, suggesting a normalisation of the HPA axis response to stressors (Messaoudi et al., 
2011). Based on this work, the central effect of the same probiotic combination in mice was 
investigated and was found that a 2-week treatment with the probiotic formulation attenuated 
the HPA axis and ANS (autonomic nervous system) response to chronic stress. This was 
reflected by a decrease in plasma levels of corticosterone, adrenaline, and noradrenaline in 
stressed mice (Ait-Belgnaoui et al., 2014). As a further confirmation of the interaction 
between the intestinal microbiota and the stress response, chronic treatment with L. 
rhamnosus was able to decrease the levels of stress-induced corticosterone and ameliorate 
anxiety-like and depressive-like behaviours in mice (Bravo et al., 2011). Interestingly, as 
stated previously, the neurochemical and behavioural effects were not observed in 
vagotomized animals, thus suggesting that the vagus nerve might play a key role in the 




with C. rodentium in mice caused a stress-induced memory impairment which was attenuated 
by pretreatment with a combination of probiotics (L. rhamnosus and L. helveticus) (Gareau et 
al., 2011). In the same study, HPA axis activation was assessed by measuring levels of serum 
corticosterone, with exposure to psychological stress (water avoidance stress) causing a 
significant increase in serum corticosterone levels that was ameliorated by probiotics 
administration (Gareau et al., 2011). 
 
Prebiotics were first defined as “nondigestible food ingredients that beneficially affect the 
host by selectively stimulating the growth and/or activity of one or a limited number of 
bacteria in the colon, thus improving host health” (Gibson and Roberfroid, 1995) but this 
concept has been expanded more recently (Bindels et al., 2015). The prebiotic sialyllactose 
reduced stress-induced intestinal microbial disruption and anxiety-like behaviour thus 
confirming the hypothesis that the gut microbiota may play a crucial role in response to stress 
exposure (Tarr et al., 2015). This prebiotic, however, was not able to reverse the increases of 
corticosterone caused by the stressor. Work from our laboratory has recently shown that 
healthy mice treated with the prebiotics fructooligosaccharide (FOS) and 
galactooligosaccharide (GOS) for 3 weeks exhibited a reduction in stress-induced 
corticosterone release and had anxiolytic effects. In addition, the prebiotic combination was 
able to normalise the effects of chronic psychological stress on the microbiota (Burokas et al., 
2017). From a translational perspective, GOS intake by healthy volunteers was associated 
with decreased waking salivary cortisol levels and altered attentional bias compared to 
placebo (Schmidt et al., 2015). These results suggest that the prebiotic intake may modulate 
the HPA axis activity in a similar way as probiotics. Depletion of gut microbiota can also 
alter stress responses and behaviour. For example, perturbation of the maternal gut 
microbiota during pregnancy, induced by administration of antibiotics, was able to influence 




anxiety-like behaviour thus suggesting that disruption of maternal gut microbiota during 
pregnancy may lead to alterations in the behaviour of their offspring (Tochitani et al., 2016). 
To corroborate the previous findings, an anxious or non-anxious phenotype can be induced 
with a microbiota transplant from an animal with a similar phenotype (Bercik et al., 2011a) 
and our lab has demonstrated that transplantation of faecal microbiota from depressed 
patients into healthy rats was able to induce an anxiety-like phenotype (Kelly et al., 2016). In 
these studies based on microbiota depletion and faecal transplantation, the neuroendocrine 
component is often missing. A deeper investigation will be needed to elucidate the role that 
neurohormones play in the different behavioural outcomes. 
 
6.1 Psychotropic Drugs and Gut Microbiota 
With regard to stress and stress-related disorders, it is relevant to mention that some brain-
targeting drugs have been shown to possess antimicrobial properties. Chronic treatment with 
the atypical antipsychotic olanzapine, for example, was able to induce changes in gut 
microbiota composition in rats (Davey et al., 2013). These microbiota changes appear to be 
responsible for the metabolic impairment caused by olanzapine; in fact, co-administration of 
an antibiotic cocktail in olanzapine-treated rats attenuated the metabolic dysfunction induced 
by olanzapine alone (specifically: body weight gain, uterine fat deposition, macrophage 
infiltration of adipose tissue and plasma free fatty acid levels) (Davey et al., 2013). 
Antidepressants can also alter gut microbiota. Tricyclic antidepressants (TCAs) are reported 
to prevent the growth of intestinal pathogens such as E. coli, Yersinia enterocolitica (Csiszar 
and Molnar, 1992; Molnar, 1988) and the parasite Giardia lamblia (Weinbach et al., 1992). 
TCAs also present in vitro activity against the parasites Plasmodium falciparum (Basco and 
Le Bras, 1990; Salama and Facer, 1990) and Leishmania spp. (Zilberstein and Dwyer, 1984). 
Another class of antidepressants, selective serotonin reuptake inhibitors (SSRIs), including 




especially against gram-positive bacteria such as Staphylococcus and Enterococcus (Ayaz et 
al., 2015; Coban et al., 2009). The antimicrobial activity of some antidepressants is further 
confirmed by the synergistic effect of some SSRIs in combination with antibiotics; as well as 
their effects against some antibiotic-resistant bacteria (Bohnert et al., 2011; Munoz-Bellido et 
al., 1996, 2000). 
While the majority of the results to date derive from in vitro studies, they represent a 
preliminary step for a more comprehensive investigation of how brain-targeting drugs might 
influence gut microbiota and impact on neuroendocrine pathways. 
 
7. Gut Microbiota and Eating Behaviour 
Eating behaviour and appetite are regulated by a complex system of central and peripheral 
signals. Peripheral regulation includes satiety and adiposity signals, while central control is 
accomplished by several effectors, including the neuropeptidergic, monoaminergic and 
endocannabinoid systems. Satiety signals such as CCK, GLP-1 and PYY are produced in the 
EECs during a meal and, through the vagus nerve signal to the nucleus tractus solitarius 
(NTS) in the brain. From NTS, afferents fibres project to the arcuate nucleus (ARC), where 
satiety signals are integrated with adiposity signals, leptin and insulin, and with several 
hypothalamic inputs. Another brain area involved in appetite regulation is the PVN, 
responsible of producing anorexigenic peptides such as thyrotropin releasing hormone (TRH) 
(Guo et al., 2004), CRF (Krahn et al., 1988; Smith et al., 2001; Uehara et al., 1998) and 
oxytocin (Lawson et al., 2015). The most immediate mechanism through which the gut 
microbiota modulates food intake is through the production/alteration of appetite-regulating 
hormones (see Section 5.5). EECs express Toll-like receptors which, when activated by 
binding with bacterial products (e.g., lipopolysaccharides (LPS) and flagellin), modify the 
secretion of hormones that regulate satiety and hunger (Raybould, 2010a). It is currently 




microbiota composition (Conlon and Bird, 2014; De Filippo et al., 2010; Queipo-Ortuno et 
al., 2013; Wu et al., 2011); however the converse might also be true. Increasing evidence 
supports the concept that the gastrointestinal microbiota composition and richness may be 
responsible, together with other factors, for the host eating behaviour and appetite (Alcock et 
al., 2014; Fetissov, 2017; Goyal et al., 2015; Norris et al., 2013). Indeed, the symbiotic 
microorganisms residing in the intestine are dependent upon host feeding behaviour to 
receive the nutrients necessary for their growth (Dethlefsen et al., 2007). The gut microbiota 
is characterised by its own circadian rhythmicity, which means it undergoes diurnal 
fluctuations in composition and in the production of key metabolic mediators (Leone et al., 
2015; Liang et al., 2015; Thaiss et al., 2014; Zarrinpar et al., 2014). It has been shown that 
the consumption of a high-calorie diet in mice, affecting the gut microbiota, altered the 
function of the mammalian circadian clock and changed the period of the locomotor activity 
(Kohsaka et al., 2007). Healthy humans and rats normally display autoantibodies directed 
against appetite-regulating peptide hormones and neuropeptides, which may have physiologic 
implications in hunger and satiety pathways (Fetissov et al., 2008). Indeed, IgG and IgA 
autoantibodies directed against leptin, ghrelin, peptide YY, neuropeptide Y, and other 
appetite-regulating peptides were decreased in germ-free rats compared with specific 
pathogen-free (SPF) rats, thus involving a change in the behavioural outcome (Fetissov et al., 
2008). Increasing evidence suggests that metabolites produced by the colonic microbiota, 
such as SCFAs, modulate feeding behaviour via central mechanisms (Frost et al., 2014; Shen 
et al., 2009; So et al., 2007). Indeed, administration of a dietary compound that selectively 
augments propionate production in the colon of healthy humans, attenuated reward-based 
eating behaviour via striatal pathways, thus suggesting a key role for the propionate-
producing intestinal microbiota (Byrne et al., 2016). These beneficial effects, however, were 
not accompanied by alterations in hormonal levels of PYY and GLP-1, as initially 




choice (Alcock et al., 2014). In Drosophila melanogaster, lack of any essential amino acid 
from the diet usually induces fruit flies to have a strong appetite for proteinaceous food. 
However, flies that receive an appropriate microbiome do not develop this protein appetite, 
suggesting that the microbiota is able to mediate appetite response. Specifically, the gut 
bacteria species that suppress protein appetite are Acetobacter pomorum and Lactobacilli 
(Leitao-Goncalves et al., 2017). In this intriguing study using Drosophila, the role of 
hormonal secretions in mediating the effect of microbial changes was not investigated per se. 
 
The investigation of the connection between obesity, eating behaviour and the gut microbiota 
has involved the use of gut-targeting supplements such as prebiotics and probiotics (Torres-
Fuentes et al., 2015, 2017). Among others, inulin, β-glucan and FOS are fermentable 
carbohydrates that have been shown to modulate the intestinal microbiota by increasing the 
proportions of bifidobacteria and lactobacilli in humans (Tuohy et al., 2001). Several studies 
have reported that the modulation of microbiota activity using different non-digestible 
carbohydrates affects appetite (Bird et al., 2010; Daud et al., 2014; Delzenne et al., 2013; 
Frost et al., 1999; Klosterbuer et al., 2012; Nilsson et al., 2013; Robertson, 2012; Tarini and 
Wolever, 2010). The role of FOS in mice fed a standard diet and in mice fed two distinct high 
fat diets (one of which carbohydrate-free) has recently been investigated. In normal mice, 
FOS induced an increase in total caecum weight, a significant decrease in epididymal fat 
mass and an increase in colonic and portal plasma GLP-1. In the high-fat carbohydrate-free 
diet group, FOS decreased energy intake, body weight gain, glycemia, and epididymal fat 
mass, suggesting that dietary oligosaccharides promote, in certain conditions, endogenous 
GLP-1 production with beneficial physiological consequences (Delmee et al., 2006). In a 
recent study the administration of both β-glucan and inulin attenuated weight gain in high fat 
fed mice (Arora et al., 2012), confirming findings of others (Cani et al., 2004; Cani et al., 




and obese humans was able to induce weight loss and improve glucose regulation in 
overweight adults. Interestingly, this was associated with decreases in ghrelin levels and 
increases in PYY (Parnell and Reimer, 2009). Similarly, food intake, body weight and fat 
mass were all decreased in male Wistar rats after administration of three different prebiotics 
(Cani et al., 2004). It was also found that microbial fermentation of oligofructose increased 
satiety, reduced hunger and reduced the desire to ingest food in humans (Cani et al., 2006). 
Although the mechanisms responsible for such effects were not fully understood, it is known 
that oligofructose stimulates the release of GLP-1 (Delzenne et al., 2007), thus this might be 
one mechanism through which it exerted its beneficial effects. The increased satiety and 
reduced hunger caused by highly fermented prebiotics were associated with changes in 
plasma GLP-1 and PYY levels (Cani et al., 2009). 
 
Another means of targeting the microbiome to alter metabolic function is via probiotics. 
Several studies have shown that probiotic administration is able to influence host satiety and 
eating behaviour, as well as playing a role in obesity (Arora et al., 2013; Belguesmia et al., 
2016; Delzenne et al., 2011; Forssten et al., 2013). Here from a neuroendocrine perspective 
we will focus our attention on evidence that links probiotic administration, and therefore 
microbiota composition/stability, to eating behavior per se. It was recently shown that the 
administration of certain probiotic Lactobacillus strains were able to modify the levels of 
circulating satiety hormones, thus affecting food intake in rats (Forssten et al., 2013). In a 
recent study, the probiotic L. rhamnosus CGMCC1.3724 was administered to obese men and 
women over a period of 24 weeks and produced a significant sex-dependent effect. In fact, 
only in women, the weight loss in the probiotic group was significantly higher than that the 
placebo group. Interestingly, this weight loss in females was associated with significant 
reductions in circulating leptin concentrations (Sanchez et al., 2014). In another study, the 




resistance via modulation of the gut microbiota composition. In addition, VSL#3 promoted 
the release of the hormone GLP-1, resulting in reduced food intake and improved glucose 
tolerance (Yadav et al., 2013). In a study conducted on Iraqi obese females, the consumption 
of probiotics caused an increase in peptide YY, a decrease of ghrelin and a subsequent 
decrease in body weight (Alajeeli, 2016). The impact of prenatal exposure to probiotics on 
weight gain has also been assessed. L. rhamnosus administered to pregnant women has been 
found to modify the standard of weight gain in children during the first six months of life 




Several factors are known to contribute to obesity and metabolic disorders, such as the 
environment, life style, diet and genetics (Naukkarinen et al., 2012). Emerging evidence 
supports the notion that changes in gut microbiota composition and/or richness are correlated 
to obesity and this can occur in a causative way (Backhed et al., 2004; Ley et al., 2006; 
Ridaura et al., 2013; Turnbaugh et al., 2009b). In a landmark study, Bäckhed et al. 
demonstrated that germ-free mice have less total body fat than conventionally reared mice 
and the colonisation of germ-free mice with a caecal microbiota harvested from 
conventionally raised animals produces an increase in body fat content and insulin resistance 
(Backhed et al., 2004). In addition, germ-free mice have an increased preference and intake 
of fats compared to normal mice. This is associated with decreased intestinal expression of 
satiety peptides CCK, PYY and GLP-1 (Duca et al., 2012). In the same study, germ-free mice 
had lower levels of circulating leptin and ghrelin, and altered plasma lipid metabolic markers 
indicative of energy deficits (Duca et al., 2012). Both obese humans and mice have been 
shown to have a specific microbial profile that is different from lean people, with the relative 




Moreover, the obese microbiome showed an increased capacity to harvest energy from the 
diet, a trait that was transmitted through microbial transplantation. In fact, colonisation of 
germ-free mice with an obese microbiota resulted in a significantly greater increase in total 
body fat than colonization with a lean microbiota (Turnbaugh et al., 2006). Importantly, the 
contribution of hormonal signalling in the onset of metabolic changes following faecal 
transplantation needs further investigation. Turnbaugh and colleagues also showed that a core 
gut microbiome is shared within lean or obese twins (Turnbaugh et al., 2009a) and many 
other studies have confirmed the specificity of the obese microbiota (Le Chatelier et al., 
2013; Million et al., 2013; Ravussin et al., 2012; Ridaura et al., 2013; Ussar et al., 2015). 
Nevertheless, it has been shown that, when obesity is driven by the diet, the intestinal 
microbiome does not play a role in the onset of the obese phenotype (Rabot et al., 2016). In a 
cohort study, a combination of delivery mode, maternal pre-pregnancy BMI (body mass 
index) and antibiotics in infancy influenced the risk of being overweight in later childhood 
(Ajslev et al., 2011). Several other studies have supported the idea that administration of 
antibiotics during childhood increases the risk of obesity, thus demonstrating that the gut 
microbiota composition/stability may play a key role in the onset of obesity (Azad et al., 
2014; Scott et al., 2016; Trasande et al., 2013). Even though many studies support the role of 
Bifidobacteria on the host fatty acid metabolism, strain-strain differences are important 
factors influencing the modulation of the gut microbial community (Wall et al., 2012). 
Therefore, more studies should aim to clarify the role of specific Bifidobacterium species and 
strains in obesity and weight management (Wall et al., 2012). Circadian rhythms regulate 
several aspects of physiology including metabolism and play a critical role in obesity (Bray 
and Young, 2007; Froy, 2010). The gut microbiota has been shown to contribute to 
accelerated post-dieting weight regain. Thaiss and colleagues found an intestinal microbiota 
signature that persisted after successful dieting of obese mice and contributed to faster weight 





7.2 Anorexia Nervosa 
Anorexia nervosa is a complex psychiatric disorder characterized by aberrant eating 
behaviour aimed at maintaining a low body weight because of the patient's pathological fear 
of weight gain, associated with alterations in the perception of the body shape (Kaye et al., 
2009). From a neuroendocrine perspective, several studies have shown that subjects with 
anorexia nervosa have altered concentrations of the appetite-regulating hormones PYY 
(Germain et al., 2007; Nakahara et al., 2007), leptin (Monteleone et al., 2000) and ghrelin 
(Harada et al., 2008; Monteleone et al., 2008). Interestingly, also CRF (Glowa et al., 1992; 
Hotta et al., 1986) and oxytocin (Demitrack, 1990; Lawson et al., 2011; Lawson et al., 2012) 
have been found to be altered in patients suffering from anorexia nervosa.  
In a recent population-based study, it has been shown that in comparing the intestinal 
microbiota of patients with anorexia nervosa to that of healthy controls, the alpha diversity 
was significantly lower in patients with anorexia both before and after inpatient weight 
restoration (Kleiman et al., 2015). Moreover, the microbial composition in the anorexic 
cohort was correlated with mood (Kleiman et al., 2015). An increase in Methanobrevibacter 
smithii has been detected in the intestinal microbiota of anorexic patients as compared to lean 
humans (Armougom et al., 2009) while others reported a decreased richness in the microbiota 
of anorexic patients (Morita et al., 2015). Interestingly, the microbial perturbations and 
gastrointestinal symptoms seen in anorexic patients did not recover after weight gain and/or 
normalisation of eating behaviour (Mack et al., 2016).  
 
8. Gut Microbiota and Sexual Behaviour 
Unlike other behavioural fields, very little is currently known of the connection between the 
gut microbiota, neurohormones and sexual behaviour. Almost sixty years ago, in 1959, 




to the outside of an individual and received by a second individual of the same species in 
which they release a specific reaction, for example, a definite behaviour or developmental 
process” (Karlson and Luscher, 1959). Among the pheromones, sex pheromones are the ones 
responsible for sexual recognition, attraction and mating behaviour in several species. 
Interestingly, research now suggests that the gut microbiota may play a role in regulating 
sexual behaviour, with the discriminative urinary odours present in conventional housed rats 
being abolished in germ-free rats, indicating a key role of bacteria in determining the unique 
odours responsible for the host behaviour (Singh et al., 1990). Moreover, it has been shown 
that the gut bacteria of locusts are responsible for the production of guaiacol, a key 
component of pheromones responsible for mating. This was further confirmed by the fact that 
the faecal pellets of locusts grown in germ-free conditions smelled different from those from 
locusts with a normal gut microbiota and did not have guaiacol (Dillon et al., 2000, 2002). 
Even though some animals do not have a gut microbiota per se, they possess symbiotic 
bacteria that in some cases have been linked to sexual behaviour. Intriguingly, it has recently 
been demonstrated that symbiotic bacteria can influence mating preference by changing the 
levels of cuticular hydrocarbon sex pheromones in the Drosophila (Sharon et al., 2010). In 
this study, a population of Drosophila melanogaster was divided in two parts, one reared on a 
molasses medium and the other on a starch medium. When the isolated populations were 
mixed, “molasses flies” preferred to mate with other molasses flies and “starch flies” 
preferred to mate with other starch flies. Furthermore, antibiotic treatment was able to abolish 
the mating preference, suggesting that the fly microbiota was affecting host pheromone 
levels, which in turn affected mating behaviour (Sharon et al., 2010). Interestingly, 
administration of the probiotic L. reuteri has been shown to increase testosterone levels in 
aging mice (Poutahidis et al., 2014).  
Oxytocin is released by the posterior pituitary gland, acts also as mediator of sexual 




suggests that the gut microbiota is able to directly modulate the levels of host oxytocin 
(Poutahidis et al., 2013; Varian et al., 2017) and so it is interesting to speculate as to whether 
the microbiota contributes towards regulation of sexual behaviour. These preliminary results 
suggest that the gut microbiota may play a key role in sexual behaviour. Importantly, most of 
the studies to date have been focusing on interactions between the microbiome and 
pheromones, and more effort will be needed to elucidate the role played by the conventional 
neuroendocrine routes. 
 
9. Gut Microbiota and Social Behaviour  
Sociability is a key aspect of mammals’ lifespan. In the last decades, numerous studies have 
been focusing on how social interactions take place across different species and some studies 
have suggested that the endosymbiotic microbes shared in group living have influenced the 
evolution of social behaviour (Lombardo, 2008; Montiel-Castro et al., 2013; Troyer, 1984). 
The microbiota has been linked to social status across a variety of species including 
Drosophila (Lize et al., 2014; Venu et al., 2014), bumblebees (Koch and Schmid-Hempel, 
2011), hyenas (Theis et al., 2013), non-human primates in the wild (Tung et al., 2015) and 
rodents.  
Oxytocin and vasopressin are neuropeptides of the hypothalamus-neurohypophyseal axis and 
play a critical role in social bonding (Meyer-Lindenberg et al., 2011) and, as mentioned 
above, the gut microbiota is able to modulate levels of the hormone oxytocin (Erdman and 
Poutahidis, 2016; Varian et al., 2017) thus potentially impacting on social behaviour. In a 
recent study, we demonstrated that mRNA levels of oxytocin and vasopressin were 
significantly reduced in the hypothalamus of antibiotic-treated adolescent mice when 
compared to non-treated mice, suggesting that gut microbes are able to modulate the activity 
of these hormones (Desbonnet et al., 2015). These biological changes were accompanied by 




performance in the social transmission of food preference test (Desbonnet et al., 2015). We 
also assessed the social motivation and preference for social novelty in germ-free mice 
through the three-chambered sociability test (Yang et al., 2011) and demonstrated that germ-
free animals suffer a social impairment, which is reversed by re-colonisation with a normal 
microbiota (Desbonnet et al., 2014). The gut microbiota is crucial for the presence of a 
normal social behaviour in mice (Buffington et al., 2016b). Furthermore, offspring of high-
fat-fed mothers have fewer oxytocin immune-reactive neurons in the hypothalamus 
associated with social behavioural deficits, which are mediated by alterations in the offspring 
gut microbiome (in which the relative abundance is dramatically reduced) (Buffington et al., 
2016a). In the same study, the administration of L. reuteri in the drinking water of the 
offspring was able to restore oxytocin levels and improve sociability and the preference for 
social novelty.  
 
9.1 Autism Spectrum Disorder 
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder defined by deficits in 
social interaction and communication and the presence of limited, repetitive stereotyped 
interests and behaviours (NIH, 2017). Very little is currently know about the 
neuroendocrinology of autism, however, some studies have addressed the role of sex 
differences in autistic symptomatology, the majority of which showing that males are more 
prone to develop ASD than females (Baron-Cohen et al., 2011; Pfaff et al., 2011). These data 
however, should be interpreted with caution as females girls tend to be more socially driven 
than males (Christov-Moore et al., 2014; Connellan et al., 2000), therefore some mildly 
affected females might go unrecognized. A factor responsible for gender differences in ASD 
might be that males are exposed to higher intrauterine testosterone levels than females 
(Hines, 2006; Hines et al., 2015), with fetal testosterone associated to autistic traits and 




1990; Eisenegger et al., 2011). It is important to remember that one of the main features of 
ASD is social impairment, suggesting that the neuroendocrinology of autism and social 
behaviour might overlap. As mentioned above, the neuropeptides oxytocin (OXT) and 
arginine vasopressin (AVP) are key mediators of complex social behaviours including 
attachment, social recognition and aggression (Dölen et al., 2013; Heinrichs et al., 2009; 
Neumann and Slattery, 2016). Indeed, central administration of OXT in the olfactory bulb 
facilitates and prolongs social recognition in male rats (Dluzen et al., 2000; Dluzen et al., 
1998). Also in female rats and mice, OXT is a crucial factor in social cognition. In female 
rats, intracerebroventricular administration of an OXT antagonist interfered with the animals’ 
ability to establish normal social memory (Engelmann et al., 1998). Vasopressin, on the other 
side, has primarily been implicated in male typical social behaviours, including aggression, 
pair-bond formation, and in stress response (Goodson and Bass, 2001). 
Three recent studies using animal models based on clinically validated risk factors of autism 
[Maternal exposure to 1) valproic acid (VPA), 2) high fat diet and 3) inflammation] 
illuminate a role of the microbiome in mediating behavioural changes relevant to ASD 
(Buffington et al., 2016b; de Theije et al., 2014; Hsiao, 2013). In utero exposure to VPA 
induced deficits in social interaction in mice and had a transgenerational impact on gut 
microbiota in the offspring. Moreover, this was associated with changes in social behaviour 
scores (de Theije et al., 2014). The maternal immune activation (MIA) mouse model is 
known to display features of autism and social impairment. Hsiao et al. showed that 
administration of Bacteroides fragilis to MIA mice was able to ameliorate deficits in 
communicative, stereotypic, anxiety-like and sensorimotor behaviour. Moreover, treating 
naive mice with a metabolite that is increased by MIA and normalized by B. fragilis resulted 
in behavioural abnormalities, supporting the idea that gut bacteria exert a crucial impact on 
behaviour (Hsiao et al., 2013). A recent study also proved that behavioural abnormalities of 




bacteria. Indeed, pre-treatment of MIA mothers with the antibiotic vancomycin prevents the 
development of behavioural deficits in the offspring (Kim et al., 2017). Studies of the gut 
microbiota in children with ASD are limited in quantity and quality; however, some have 
pointed out differences in the microbiota composition between ASD and healthy children 
(Finegold et al., 2010; Kang et al., 2013; Parracho et al., 2005). To decrease the heterogeneity 
of findings and strengthen them, future studies should enlarge sample sizes, standardize 
methods and assess relevant confounding variables among ASD populations. Finally, further 
investigations will be needed to better assess the role of neuroendocrine signalling in autistic-
like behaviours mediated by the microbiota.  
 
10. Gut Microbiota, Learning and Memory 
Learning and memory are complex processes finely regulated by specialized neuronal 
networks. The hormones oxytocin and vasopressin play a fundamental role in this inter-
neuronal communication and several studies have demonstrated the involvement of these 
hormones in cognitive processes (Bohus et al., 1978; Dantzer et al., 1987; Ibragimov, 1990; 
Till and Beckwith, 1985). Moreover, some evidence also suggests that glucocorticoids levels 
are linked to memory and learning (Hui et al., 2004; Oitzl et al., 1998; Roozendaal and 
McGaugh, 1997). Neuroendocrine mechanisms are very important in supporting cognitive 
function across the lifespan (Almey et al., 2015; Lupien et al., 2007; McEwen et al., 2015). 
Moreover, postnatal gut microbial colonisation occurs in parallel with cognitive development 
(Alexeev et al., 2017) and evidence has shown that colonisation by gut microbiota impacts 
mammalian brain development and subsequent adult behavior (Diaz Heijtz et al., 2011). 
Germ-free mice, with or without exposure to stress, have memory impairments, thus 
demonstrating a decisive role for the gut microbiota in cognition (Gareau et al., 2011). In the 
same study, it was shown that infection with C. rodentium in conventionally colonised mice 




pre-treatment of C. rodentium-infected mice with a combination of Lactobacillus-containing 
probiotics prevented stress-induced memory deficits and ameliorated serum corticosterone 
levels. In another study, ingestion of B. breve NCIMB702258, but not B. breve 6330, 
significantly impacted brain fatty acid composition in mice, increasing arachidonic acid (AA) 
and docosahexaenoic acid (DHA) levels, with potential clinical implications, as these fatty 
acids play important roles in cognitive processes such as memory and learning (Wall et al., 
2012). In a further preclinical study, a positive effect of probiotic supplementation on 
diabetes-induced cognitive impairments in rats was observed (Davari et al., 2013). We have 
shown that antibiotic-treated adolescent mice had non-spatial memory deficits and reduced 
oxytocin mRNA levels (in the hypothalamus) when compared to non-treated mice 
(Desbonnet et al., 2015). Moreover, administration of L. rhamnosus in mice was able to not 
only decrease the stress response (see section 6) but to also enhance memory of an aversive 
cue and context in comparison with broth-fed mice (Bravo et al., 2011), reducing the levels of 
corticosterone. Interestingly, it has recently been shown that germ-free mice are not impaired 
in the acquisition of a fear learning response but have marked deficits in fear recall (Hoban et 
al., 2017). In another study, it has been shown that dietary-induced shifts in bacterial diversity 
were correlated with changes in memory and learning in mice (Li et al., 2009). 
Administration of E. coli and subsequent alterations in the gut microbial composition in mice 
resulted in memory impairments (Jang et al., 2017). Work from our laboratory demonstrated 
that prenatal stress in rats not only induces marked changes in the gut microbiota composition 
but also impairs cognitive function (Golubeva et al., 2015). Moreover, the microbial changes 
present in aged mice might be mediators of impaired cognitive performance and anxiety-like 
behaviour characteristic in late life (Scott et al., 2017). It was recently shown that the 
microbiota composition of human infants at one year of age predicts cognitive performance at 
2 years of age, mostly in the area of communicative behaviour. (Carlson et al., 2017). 




male volunteers improves visuospatial memory and produces an electroencephalography 
profile consistent with improved memory (Allen et al., 2016). 
Taken together these data highlight a role for the gut microbiota in both baseline and stress-
related cognitive changes. More work is needed to determine the interactions between 
neuroendocrine systems and the microbiome in determining these effects (Dinan and Cryan, 
2017). Moreover, there is a growing body of evidence linking the microbiome to ageing 
processes and Alzheimer’s disease. Though a causal association between gut microbes and 
cognitive decline in the elderly has not yet been reported, some studies have demonstrated the 
specificity of the core microbiota in elderly subjects as opposed to young subjects (Claesson 
et al., 2011; Claesson et al., 2012) and in animal models of ageing. Moreover, neither germ-
free nor antibiotic-treated transgenic Alzheimer’s mice develop the characteristic plaques 
(Harach et al., 2015; Minter et al., 2016). In light of the results to date, it is tempting to 
speculate that changes in the elderly microbiota may modulate inflammatory and hormonal 
processes that act in the brain and impact on cognitive decline.  
 
11. Gut Microbiota and Addiction 
Stress represents one of the major susceptibility factors for the development of addictive 
behaviour and substantial evidence shows that the HPA axis and corticosteroids play a crucial 
role in the process of addiction (Ambroggi et al., 2009; Mantsch et al., 2007a; Yang et al., 
2004). Interestingly, CRF is involved in the onset/development of addiction (Koob, 2010; 
Sarnyai et al., 2001) but the data are not always consistent. For example, cocaine has been 
shown to stimulate the HPA axis through a CRF-mediated mechanism in male rats (Goeders, 
1997, 2002), and both CRF mRNA levels and circulating corticosterone are increased on 
cocaine withdrawal (Mantsch et al., 2007b). In contrast, shock-induced reinstatement of 
heroin or alcohol seeking depends on CRF, but not on corticosterone (Le et al., 2000; 




studies have suggested that females are more susceptible than males (Devaud et al., 2003; 
Festa et al., 2004) and that this might be due to gonadal hormones (Festa et al., 2004), 
however more research is required to confirm this hypothesis. There is a complex overlap 
between the neurobiology of addiction and more prototypical neuroendocrine behaviours 
such as food intake, sexual and social behaviours. There is also a burgeoning literature on the 
influence of the microbiome on addictive behaviours. Several studies have shown that 
alcoholism and cocaine addiction induce changes in gut microbiota composition (Leclercq et 
al., 2014; Mutlu et al., 2009; Mutlu et al., 2012; Peterson et al., 2017; Volpe et al., 2014; Yan 
et al., 2011) while others suggest that the gut microbiota might influence to some extent the 
onset/development of addictive behaviours. For instance, it is well established that stress is 
one of the most significant risk factors for addiction (Sinha and Jastreboff, 2013) and, as 
described in section 6, the stress response is modulated by the functional state of the gut 
microbiota. Translating this finding to humans, perturbations of the gut-brain axis and 
therefore altered stress response could predispose an individual to addiction. Another known 
risk factor that can also be comorbid with addiction is depression (Polter and Kauer, 2014). 
One of the main neurotransmitters involved in depression is serotonin (Nemeroff, 2002; 
Owens and Nemeroff, 1994) and it is recognised that 90% of the body serotonin is 
synthetized in the gut (Yano et al., 2015). Thus, the microbiota-derived modulation of 
serotonin levels might indirectly influence the development or onset of addiction. Finally, it 
is now well established that most drugs of abuse affect the brain via central dopamine-reward 
pathways (Volkow and Baler, 2015) and that the gut microbiota is a source of dopamine. As a 
confirmation of this, germ-free mice display lower levels of dopamine in the caecum than 
specific-pathogen-free mice (Asano et al., 2012). These findings provide evidence of a link 
between gut microbiota and dopamine function, which could have implications for addiction. 
Oxytocin has been linked to addiction and chronic administration of drugs of abuse such as 




al., 2001; Johns et al., 1997; Sarnyai et al., 1992). Indeed, individual differences in oxytocin 
levels may be responsible for the host resilience and the susceptibility to develop problematic 
drug and alcohol abuse (Buisman-Pijlman et al., 2014). At the same time, mounting 
preclinical evidence is suggesting that oxytocin might represent a novel treatment for 
addictive disorders (Lee et al., 2016; McGregor and Bowen, 2012). Given that the gut 
microbiota has been shown to be involved in modulation of oxytocin levels in the brain 
(Desbonnet et al., 2015), it is reasonable to suppose that intestinal microbes might play a role 
in addiction. Only one study has directly linked the gut microbiota to addictive behaviour and 
has shown that alterations of the gut microbiota in mice affect the behavioural response to 
cocaine. Following prolonged treatment with non-absorbable antibiotics, the animals showed 
an enhanced sensitivity to cocaine reward and enhanced sensitivity to the locomotor-
sensitizing effects of repeated cocaine administration (Kiraly et al., 2016). 
Even though the findings to date are not exhaustive, they provide some evidence of the link 
between gut microbiota, neuroendocrinology and addiction. Further investigation is required 
in order to assess which other neuroendocrine pathways are involved in addiction and in 
which cases the gut microbiota plays a causal role. 
 
12. Conclusion  
Increasing evidence suggests that the gut microbiota affects different physiological and 
behavioural outcomes through modulation of neuroendocrine pathways. The production of 
hormones and neuroactive metabolites from the gastrointestinal tract influences distal sites 
and ultimately results in central activation and behavioural changes. The aim of this review 
was to present and discuss different behavioural scenarios that have been linked, to certain 
extent, to modifications of the intestinal microbiota and neuroendocrine pathways. However, 
the results to date come mainly from preclinical studies and further clinical experimentation 




Moreover, future studies should address the contribution of sex differences in the behavioural 
outcomes mediated by endocrine routes. Intriguingly, some researchers have pointed out that 
the host gender represents a key variable in stress-related behaviours (Bale, 2011; Mueller 
and Bale, 2008; Shansky, 2009; Shansky et al., 2010) and, given the hormonal discrepancies 
present among males and females, a deeper investigation of this aspect is required. Finally, it 
is important to note that the neuroendocrine system comprises two more axes, namely the 
hypothalamic-pituitary-liver axis and the hypothalamic-pituitary-prolactin axis, that have not 
been taken into consideration in this review due to the lack of direct links with the gut 
microbiota and/or behavioural outcomes. However, given the expansive nature of how the 
microbiome affects the programming of all body systems it is probably only a matter of time 
before it is also implicated in these axes in addition to affecting the hypothalamus-pituitary-
thyroid axis. The investigation of the interactions between gut microbiota and these 
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Figure 1. Using rodent models to assess the impact of the microbiota-gut-brain axis on host 
behaviour. Neuroendocrine pathways mediate the behavioural effects induced by 
manipulations/alterations of the gut microbiota. Abbreviations: T testosterone, OXT oxytocin, 
CORT cortisol (humans) corticosterone (rodents), ACTH adrenocorticotropic hormone, PYY 







Figure 2. The gut microbiota influences neuroendocrine function through several routes that 
characterize the microbiota-gut-brain axis. These routes include the vagus nerve, production 
of SCFAs, immune activation with production of immune mediators, production of 
neurotransmitters and tryptophan. The gut microbiota is also able to convert primary bile 
acids into secondary bile acids, which activate receptors on EECs and stimulate the secretion 
of gut peptides. Neuroactive compounds produced by gut microbiota enter the circulation and 
reach the brain, subsequently affecting neuroendocrine function. Abbreviations: 5-HT (5-
hydroxytryptamine) serotonin, ACTH adrenocorticotropic hormone, CCK cholecystokinin, 
DC dendritic cell, EEC enteroendocrine cell, ENS enteric nervous system, FSH follicle-
stimulating hormone, GABA ɣ-aminobutyric acid, GLP-1 glucagon-like peptide-1, HN 
hypothalamic-neurohypophyseal axis, HPA hypothalamus-pituitary-adrenal axis, HPG 
hypothalamus-pituitary-gonadal axis, HPT hypothalamus-pituitary-thyroid axis, IL 
interleukin, LH luteinizing hormone, LPS lipopolysaccharide, NTS nucleus tractus solitarii, 
OXT oxytocin, PYY peptide YY, SCFAs short chain fatty acids, TNF-α tumor necrosis factor 







Figure 3. The immune system is a key mediator in the communication between the gut and 
the HPA (hypothalamus-pituitary-adrenal) axis. The gut microbiota regulates the release of 
cytokines TNFα, IL-1β and IL-6 into the circulation, which reach the brain and stimulate the 
release of CRF from the hypothalamus. This ultimately results in activation of the adrenal 
cortex and release of cortisol. Abbreviations: ACTH adrenocorticotropic hormone, BC B cell, 
CRF corticotrophin-releasing factor, DC dendritic cell, IL interleukin, LPS 






Ait-Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., Houdeau, E., Theodorou, V., 
Tompkins, T., 2014. Probiotic gut effect prevents the chronic psychological stress-induced brain 
activity abnormality in mice. Neurogastroenterol Motil 26, 510-520. 
Ajslev, T. A., Andersen, C. S., Gamborg, M., Sorensen, T. I., Jess, T., 2011. Childhood overweight after 
establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early 
administration of antibiotics. Int J Obes (Lond) 35, 522-529. 
Alajeeli, F., 2016. Effect of probiotic consumption in the level of peptide YY, ghrelin hormone and body 
weight in Iraqi obese female. World Journal of Pharmacy and Pharmaceutical Sciences 5, 242-248. 
Alcock, J., Maley, C. C., Aktipis, C. A., 2014. Is eating behavior manipulated by the gastrointestinal 
microbiota? Evolutionary pressures and potential mechanisms. Bioessays 36, 940-949. 
Alexeev, E. E., He, X., Slupsky, C. M., Lonnerdal, B., 2017. Effects of iron supplementation on growth, gut 
microbiota, metabolomics and cognitive development of rat pups. PLoS One 12, e0179713. 
Allen, A. P., Hutch, W., Borre, Y. E., Kennedy, P. J., Temko, A., Boylan, G., Murphy, E., Cryan, J. F., Dinan, T. 
G., Clarke, G., 2016. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of 
stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry 6, e939. 
Almey, A., Milner, T. A., Brake, W. G., 2015. Estrogen receptors in the central nervous system and their 
implication for dopamine-dependent cognition in females. Horm Behav 74, 125-138. 
Ambroggi, F., Turiault, M., Milet, A., Deroche-Gamonet, V., Parnaudeau, S., Balado, E., Barik, J., van der 
Veen, R., Maroteaux, G., Lemberger, T., Schütz, G., Lazar, M., Marinelli, M., Piazza, P. V., Tronche, F., 
2009. Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine 
seeking. Nat Neurosci 12, 247. 
Ananthaswamy, A., 2011. Faecal transplant eases symptoms of Parkinson's disease. New Scientist 209, 8-
9. 
Argiolas, A., Collu, M., Gessa, G. L., Melis, M. R., Serra, G., 1988. The oxytocin antagonist d(CH2)5Tyr(Me)-
Orn8-vasotocin inhibits male copulatory behaviour in rats. European Journal of Pharmacology 149, 
389-392. 
Armougom, F., Henry, M., Vialettes, B., Raccah, D., Raoult, D., 2009. Monitoring bacterial community of 
human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in 
anorexic patients. PLoS One 4, e7125. 
Arora, T., Loo, R. L., Anastasovska, J., Gibson, G. R., Tuohy, K. M., Sharma, R. K., Swann, J. R., Deaville, E. 
R., Sleeth, M. L., Thomas, E. L., Holmes, E., Bell, J. D., Frost, G., 2012. Differential effects of two 
fermentable carbohydrates on central appetite regulation and body composition. PLoS One 7, 
e43263. 
Arora, T., Singh, S., Sharma, R. K., 2013. Probiotics: Interaction with gut microbiome and antiobesity 
potential. Nutrition 29, 591-596. 
Asano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., Koga, Y., Sudo, N., 2012. Critical 
role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen 
of mice. Am J Physiol Gastrointest Liver Physiol 303, G1288-1295. 
Ayaz, M., Subhan, F., Ahmed, J., Khan, A. U., Ullah, F., Ullah, I., Ali, G., Syed, N. I., Hussain, S., 2015. 
Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance. J Biol 
Res (Thessalon) 22, 4. 
Azad, M. B., Bridgman, S. L., Becker, A. B., Kozyrskyj, A. L., 2014. Infant antibiotic exposure and the 
development of childhood overweight and central adiposity. Int J Obes (Lond) 38, 1290-1298. 
Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., Gordon, J. I., 2004. 
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 
101, 15718-15723. 
Bailey, M. T., 2014. Influence of stressor-induced nervous system activation on the intestinal microbiota 
and the importance for immunomodulation. Adv Exp Med Biol 817, 255-276. 
Bailey, M. T., Coe, C. L., 1999. Maternal separation disrupts the integrity of the intestinal microflora in 




Bailey, M. T., Dowd, S. E., Galley, J. D., Hufnagle, A. R., Allen, R. G., Lyte, M., 2011. Exposure to a social 
stressor alters the structure of the intestinal microbiota: implications for stressor-induced 
immunomodulation. Brain Behav Immun 25, 397-407. 
Bailey, M. T., Dowd, S. E., Parry, N. M., Galley, J. D., Schauer, D. B., Lyte, M., 2010. Stressor exposure 
disrupts commensal microbial populations in the intestines and leads to increased colonization by 
Citrobacter rodentium. Infect Immun 78, 1509-1519. 
Bailey, M. T., Lubach, G. R., Coe, C. L., 2004. Prenatal stress alters bacterial colonization of the gut in 
infant monkeys. J Pediatr Gastroenterol Nutr 38, 414-421. 
Bale, T. L., 2011. Sex differences in prenatal epigenetic programing of stress pathways. Stress 14, 348-356. 
Baron-Cohen, S., Auyeung, B., Ashwin, E., Knickmeyer, R., 2009. Fetal testosterone and autistic traits: a 
response to three fascinating commentaries. Br J Psychol 100, 39-47. 
Baron-Cohen, S., Lombardo, M. V., Auyeung, B., Ashwin, E., Chakrabarti, B., Knickmeyer, R., 2011. Why 
Are Autism Spectrum Conditions More Prevalent in Males? PLoS Biol 9, e1001081. 
Barouei, J., Moussavi, M., Hodgson, D. M., 2012. Effect of maternal probiotic intervention on HPA axis, 
immunity and gut microbiota in a rat model of irritable bowel syndrome. PLoS One 7, e46051. 
Barrett, E., Ross, R. P., O'Toole, P. W., Fitzgerald, G. F., Stanton, C., 2012. gamma-Aminobutyric acid 
production by culturable bacteria from the human intestine. J Appl Microbiol 113, 411-417. 
Basco, L. K., Le Bras, J., 1990. Reversal of chloroquine resistance with desipramine in isolates of 
Plasmodium falciparum from Central and West Africa. Transactions of the Royal Society of Tropical 
Medicine and Hygiene 84, 479-481. 
Behnia, B., Heinrichs, M., Bergmann, W., Jung, S., Germann, J., Schedlowski, M., Hartmann, U., Kruger, T. 
H. C., 2014. Differential effects of intranasal oxytocin on sexual experiences and partner interactions 
in couples. Hormones and Behavior 65, 308-318. 
Beijers, R., Jansen, J., Riksen-Walraven, M., de Weerth, C., 2010. Maternal prenatal anxiety and stress 
predict infant illnesses and health complaints. Pediatrics 126, e401-409. 
Belguesmia, Y., Domenger, D., Caron, J., Dhulster, P., Ravallec, R., Drider, D., Cudennec, B., 2016. Novel 
probiotic evidence of lactobacilli on immunomodulation and regulation of satiety hormones release 
in intestinal cells. Journal of Functional Foods 24, 276-286. 
Bellono, N. W., Bayrer, J. R., Leitch, D. B., Castro, J., Zhang, C., O'Donnell, T. A., Brierley, S. M., Ingraham, 
H. A., Julius, D., 2017. Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural 
Pathways. Cell 170, 185-198.e116. 
Bercik, P., Collins, S. M., Verdu, E. F., 2012. Microbes and the gut-brain axis. Neurogastroenterol Motil 24, 
405-413. 
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, 
K. D., Verdu, E. F., Collins, S. M., 2011a. The intestinal microbiota affect central levels of brain-
derived neurotropic factor and behavior in mice. Gastroenterology 141, 599-609, 609.e591-593. 
Bercik, P., Park, A. J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., Deng, Y., Blennerhassett, P. A., 
Fahnestock, M., Moine, D., Berger, B., Huizinga, J. D., Kunze, W., McLean, P. G., Bergonzelli, G. E., 
Collins, S. M., Verdu, E. F., 2011b. The anxiolytic effect of Bifidobacterium longum NCC3001 involves 
vagal pathways for gut-brain communication. Neurogastroenterol Motil 23, 1132-1139. 
Bernal, J., 2000. Thyroid Hormones in Brain Development and Function. In: De Groot, L. J., Chrousos, G., 
Dungan, K., Feingold, K. R., Grossman, A., Hershman, J. M., Koch, C., Korbonits, M., McLachlan, R., 
New, M., Purnell, J., Rebar, R., Singer, F., Vinik, A., (Eds), Endotext. MDText.com, Inc., South 
Dartmouth (MA). 
Bezirtzoglou, E., Tsiotsias, A., Welling, G. W., 2011. Microbiota profile in feces of breast- and formula-fed 
newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17, 478-482. 
Bharwani, A., Mian, M. F., Foster, J. A., Surette, M. G., Bienenstock, J., Forsythe, P., 2016. Structural & 
functional consequences of chronic psychosocial stress on the microbiome & host. 
Psychoneuroendocrinology 63, 217-227. 
Bilimoria, P. M., Stevens, B., 2015. Microglia function during brain development: New insights from 
animal models. Brain Res 1617, 7-17. 
Bindels, L. B., Delzenne, N. M., Cani, P. D., Walter, J., 2015. Towards a more comprehensive concept for 




Bird, A. R., Conlon, M. A., Christophersen, C. T., Topping, D. L., 2010. Resistant starch, large bowel 
fermentation and a broader perspective of prebiotics and probiotics. Benef Microbes 1, 423-431. 
Bohnert, J. A., Szymaniak-Vits, M., Schuster, S., Kern, W. V., 2011. Efflux inhibition by selective serotonin 
reuptake inhibitors in Escherichia coli. J Antimicrob Chemother 66, 2057-2060. 
Bohus, B., Urban, I., Van Wimersma Greidanus, T. B., De Wied, D., 1978. Opposite effects of oxytocin and 
vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat. Neuropharmacology 
17, 239-247. 
Bonaz, B., Bazin, T., Pellissier, S., 2018. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. 
Frontiers in Neuroscience 12. 
Boonstra, E., de Kleijn, R., Colzato, L. S., Alkemade, A., Forstmann, B. U., Nieuwenhuis, S., 2015. 
Neurotransmitters as food supplements: the effects of GABA on brain and behavior. Front Psychol 6, 
1520. 
Bos, P. A., Panksepp, J., Bluthé, R.-M., Honk, J. v., 2012. Acute effects of steroid hormones and
neuropeptides on human social–emotional behavior: A review of single administration studies. 
Frontiers in Neuroendocrinology 33, 17-35. 
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Toth, M., Korecka, A., Bakocevic, N., Ng, 
L. G., Kundu, P., Gulyas, B., Halldin, C., Hultenby, K., Nilsson, H., Hebert, H., Volpe, B. T., Diamond, B., 
Pettersson, S., 2014. The gut microbiota influences blood-brain barrier permeability in mice. Sci 
Transl Med 6, 263ra158. 
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., Cryan, 
J. F., 2011. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor 
expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108, 16050-16055. 
Bray, M. S., Young, M. E., 2007. Circadian rhythms in the development of obesity: potential role for the 
circadian clock within the adipocyte. Obesity Reviews 8, 169-181. 
Breton, J., Tennoune, N., Lucas, N., Francois, M., Legrand, R., Jacquemot, J., Goichon, A., Guerin, C., 
Peltier, J., Pestel-Caron, M., Chan, P., Vaudry, D., do Rego, J. C., Lienard, F., Penicaud, L., Fioramonti, 
X., Ebenezer, I. S., Hokfelt, T., Dechelotte, P., Fetissov, S. O., 2016. Gut Commensal E. coli Proteins 
Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth. Cell Metab 23, 324-
334. 
Buffington, S. A., Di Prisco, G. V., Auchtung, T. A., Ajami, N. J., Petrosino, J. F., Costa-Mattioli, M., 2016a. 
Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. 
Cell 165, 1762-1775. 
Buffington, S. A., Di Prisco, G. V., Auchtung, T. A., Ajami, N. J., Petrosino, J. F., Costa-Mattioli, M., 2016b. 
Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. 
Cell 165, 1762-1775. 
Buisman-Pijlman, F. T. A., Sumracki, N. M., Gordon, J. J., Hull, P. R., Carter, C. S., Tops, M., 2014. Individual 
differences underlying susceptibility to addiction: Role for the endogenous oxytocin system. 
Pharmacology Biochemistry and Behavior 119, 22-38. 
Burokas, A., Arboleya, S., Moloney, R. D., Peterson, V. L., Murphy, K., Clarke, G., Stanton, C., Dinan, T. G., 
Cryan, J. F., 2017. Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and 
Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice. Biol Psychiatry. 
Butel, M. J., 2014. Probiotics, gut microbiota and health. Med Mal Infect 44, 1-8. 
Byrne, C. S., Chambers, E. S., Alhabeeb, H., Chhina, N., Morrison, D. J., Preston, T., Tedford, C., Fitzpatrick, 
J., Irani, C., Busza, A., Garcia-Perez, I., Fountana, S., Holmes, E., Goldstone, A. P., Frost, G. S., 2016. 
Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-
energy foods. Am J Clin Nutr 104, 5-14. 
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., Burcelin, R., 2008. Changes 
in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced 
Obesity and Diabetes in Mice. Diabetes 57, 1470-1481. 
Cani, P. D., Dewever, C., Delzenne, N. M., 2004. Inulin-type fructans modulate gastrointestinal peptides 
involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 92, 521-526. 
Cani, P. D., Joly, E., Horsmans, Y., Delzenne, N. M., 2006. Oligofructose promotes satiety in healthy 




Cani, P. D., Lecourt, E., Dewulf, E. M., Sohet, F. M., Pachikian, B. D., Naslain, D., De Backer, F., Neyrinck, A. 
M., Delzenne, N. M., 2009. Gut microbiota fermentation of prebiotics increases satietogenic and 
incretin gut peptide production with consequences for appetite sensation and glucose response 
after a meal. Am J Clin Nutr 90, 1236-1243. 
Cani, P. D., Neyrinck, A. M., Maton, N., Delzenne, N. M., 2005. Oligofructose promotes satiety in rats fed a 
high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 13, 1000-1007. 
Carlson, A. L., Xia, K., Azcarate-Peril, M. A., Goldman, B. D., Ahn, M., Styner, M. A., Thompson, A. L., Geng, 
X., Gilmore, J. H., Knickmeyer, R. C., 2017. Infant Gut Microbiome Associated with Cognitive 
Development. Biol Psychiatry. 
Carter, C. S., 1992. Oxytocin and sexual behavior. Neuroscience & Biobehavioral Reviews 16, 131-144. 
Carter, C. S., Williams, J. R., Witt, D. M., Insel, T. R., 1992. Oxytocin and Social Bondinga. Ann N Y Acad Sci 
652, 204-211. 
Choi, J. S., Kim, H., Jung, M. H., Hong, S., Song, J., 2010. Consumption of barley beta-glucan ameliorates 
fatty liver and insulin resistance in mice fed a high-fat diet. Mol Nutr Food Res 54, 1004-1013. 
Christov-Moore, L., Simpson, E. A., Coude, G., Grigaityte, K., Iacoboni, M., Ferrari, P. F., 2014. Empathy: 
gender effects in brain and behavior. Neurosci Biobehav Rev 46 Pt 4, 604-627. 
Chrousos, G. P., 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N 
Engl J Med 332, 1351-1362. 
Chrousos , G. P., 1995. The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation. 
New England Journal of Medicine 332, 1351-1363. 
Chrousos, G. P., Torpy, D. J., Gold, P. W., 1998. Interactions between the hypothalamic-pituitary-adrenal 
axis and the female reproductive system: Clinical implications. Annals of Internal Medicine 129, 229-
240. 
Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J. R., 
Falush, D., Dinan, T., Fitzgerald, G., Stanton, C., van Sinderen, D., O'Connor, M., Harnedy, N., 
O'Connor, K., Henry, C., O'Mahony, D., Fitzgerald, A. P., Shanahan, F., Twomey, C., Hill, C., Ross, R. P., 
O'Toole, P. W., 2011. Composition, variability, and temporal stability of the intestinal microbiota of 
the elderly. Proc Natl Acad Sci U S A 108 Suppl 1, 4586-4591. 
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O'Connor, E. M., Cusack, S., Harris, H. M., Coakley, 
M., Lakshminarayanan, B., O'Sullivan, O., Fitzgerald, G. F., Deane, J., O'Connor, M., Harnedy, N., 
O'Connor, K., O'Mahony, D., van Sinderen, D., Wallace, M., Brennan, L., Stanton, C., Marchesi, J. R., 
Fitzgerald, A. P., Shanahan, F., Hill, C., Ross, R. P., O'Toole, P. W., 2012. Gut microbiota composition 
correlates with diet and health in the elderly. Nature 488, 178-184. 
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., Cryan, J. F., 
2013. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic 
system in a sex-dependent manner. Mol Psychiatry 18, 666-673. 
Coban, A. Y., Tanriverdi Cayci, Y., Keles Uludag, S., Durupinar, B., 2009. [Investigation of antibacterial 
activity of sertralin]. Mikrobiyol Bul 43, 651-656. 
Conlon, M. A., Bird, A. R., 2014. The impact of diet and lifestyle on gut microbiota and human health. 
Nutrients 7, 17-44. 
Connellan, J., Baron-Cohen, S., Wheelwright, S., Batki, A., Ahluwalia, J., 2000. Sex differences in human 
neonatal social perception. Infant Behavior and Development 23, 113-118. 
Corradi, P. F., Corradi, R. B., Greene, L. W., 2016. Physiology of the Hypothalamic Pituitary Gonadal Axis in 
the Male. Urol Clin North Am 43, 151-162. 
Crumeyrolle-Arias, M., Jaglin, M., Bruneau, A., Vancassel, S., Cardona, A., Dauge, V., Naudon, L., Rabot, S., 
2014. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response 
to acute stress in rats. Psychoneuroendocrinology 42, 207-217. 
Cryan, J. F., Dinan, T. G., 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain 
and behaviour. Nat Rev Neurosci 13, 701-712. 
Cryan, J. F., O'Mahony, S. M., 2011. The microbiome-gut-brain axis: from bowel to behavior. 
Neurogastroenterol Motil 23, 187-192. 
Csiszar, K., Molnar, J., 1992. Mechanism of action of tricyclic drugs on Escherichia coli and Yersinia 




Cummings, D. E., Overduin, J., 2007. Gastrointestinal regulation of food intake. J Clin Invest 117, 13-23. 
Cummings, J. H., 1981. Short chain fatty acids in the human colon. Gut 22, 763-779. 
Dabbs, J. M., Morris, R., 1990. Testosterone, social class, and antisocial behavior in a sample of 4,462 
men. Psychol Sci 1, 209-211. 
Dallman, M. F., Akana, S. F., Levin, N., Walker, C. D., Bradbury, M. J., Suemaru, S., Scribner, K. S., 1994. 
Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann N Y 
Acad Sci 746, 22-31; discussion 31-22, 64-27. 
Dantzer, R., Bluthe, R.-M., Koob, G. F., Le Moal, M., 1987. Modulation of social memory in male rats by 
neurohypophyseal peptides. Psychopharmacology (Berl) 91, 363-368. 
Daud, N. M., Ismail, N. A., Thomas, E. L., Fitzpatrick, J. A., Bell, J. D., Swann, J. R., Costabile, A., Childs, C. E., 
Pedersen, C., Goldstone, A. P., Frost, G. S., 2014. The impact of oligofructose on stimulation of gut 
hormones, appetite regulation and adiposity. Obesity (Silver Spring) 22, 1430-1438. 
Davari, S., Talaei, S. A., Alaei, H., Salami, M., 2013. Probiotics treatment improves diabetes-induced 
impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for 
microbiome-gut-brain axis. Neuroscience 240, 287-296. 
Davey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., O'Mahony, S. M., 2013. 
Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by 
antibiotic administration in the rat. Transl Psychiatry 3, e309. 
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., 
Lionetti, P., 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in 
children from Europe and rural Africa. Proc Natl Acad Sci U S A 107, 14691-14696. 
de Kloet, E. R., Joels, M., Holsboer, F., 2005. Stress and the brain: from adaptation to disease. Nat Rev 
Neurosci 6, 463-475. 
De Kloet, E. R., Oitzl, M. S., Schobitz, B., 1994. Cytokines and the brain corticosteroid receptor balance: 
relevance to pathophysiology of neuroendocrine-immune communication. 
Psychoneuroendocrinology 19, 121-134. 
De Palma, G., Blennerhassett, P., Lu, J., Deng, Y., Park, A. J., Green, W., Denou, E., Silva, M. A., Santacruz, 
A., Sanz, Y., Surette, M. G., Verdu, E. F., Collins, S. M., Bercik, P., 2015. Microbiota and host 
determinants of behavioural phenotype in maternally separated mice. Nat Commun 6, 7735. 
De Palma, G., Collins, S. M., Bercik, P., Verdu, E. F., 2014. The microbiota-gut-brain axis in gastrointestinal 
disorders: stressed bugs, stressed brain or both? J Physiol 592, 2989-2997. 
de Theije, C. G., Wopereis, H., Ramadan, M., van Eijndthoven, T., Lambert, J., Knol, J., Garssen, J., 
Kraneveld, A. D., Oozeer, R., 2014. Altered gut microbiota and activity in a murine model of autism 
spectrum disorders. Brain Behav Immun 37, 197-206. 
De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Backhed, F., 
Mithieux, G., 2014. Microbiota-generated metabolites promote metabolic benefits via gut-brain 
neural circuits. Cell 156, 84-96. 
DeCastro, M., Nankova, B. B., Shah, P., Patel, P., Mally, P. V., Mishra, R., La Gamma, E. F., 2005. Short 
chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling 
pathway. Brain Res Mol Brain Res 142, 28-38. 
Del Rey, C., Besedovsky, 2008. the hypothalamus-pituitary-adrenal axis. 
Delmee, E., Cani, P. D., Gual, G., Knauf, C., Burcelin, R., Maton, N., Delzenne, N. M., 2006. Relation 
between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed 
mice. Life Sci 79, 1007-1013. 
Delzenne, N. M., Cani, P. D., Neyrinck, A. M., 2007. Modulation of glucagon-like peptide 1 and energy 
metabolism by inulin and oligofructose: experimental data. J Nutr 137, 2547s-2551s. 
Delzenne, N. M., Neyrinck, A. M., Backhed, F., Cani, P. D., 2011. Targeting gut microbiota in obesity: 
effects of prebiotics and probiotics. Nat Rev Endocrinol 7, 639-646. 
Delzenne, N. M., Neyrinck, A. M., Cani, P. D., 2013. Gut microbiota and metabolic disorders: How 
prebiotic can work? Br J Nutr 109 Suppl 2, S81-85. 
Demitrack, M. A., Lesem, M. D., Listwak, S. J., Brandt, H. A., Jimerson, D. C., & Gold, P. W., 1990. CSF 
oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations. 




Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T. G., Cryan, J. F., 2014. Microbiota is essential for social 
development in the mouse. Mol Psychiatry 19, 146-148. 
Desbonnet, L., Clarke, G., Traplin, A., O'Sullivan, O., Crispie, F., Moloney, R. D., Cotter, P. D., Dinan, T. G., 
Cryan, J. F., 2015. Gut microbiota depletion from early adolescence in mice: Implications for brain 
and behaviour. Brain Behav Immun 48, 165-173. 
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T. G., 2008. The probiotic Bifidobacteria 
infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 43, 164-174. 
Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., Dinan, T. G., 2010. Effects of the probiotic 
Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170, 1179-
1188. 
Dethlefsen, L., McFall-Ngai, M., Relman, D. A., 2007. An ecological and evolutionary perspective on 
human-microbe mutualism and disease. Nature 449, 811-818. 
Devaud, L. L., Alele, P., Ritu, C., 2003. Sex differences in the central nervous system actions of ethanol. Crit 
Rev Neurobiol 15, 41-59. 
Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., 
Pettersson, S., 2011. Normal gut microbiota modulates brain development and behavior. Proc Natl 
Acad Sci U S A 108, 3047-3052. 
Dickmeis, T., Weger, B. D., Weger, M., 2013. The circadian clock and glucocorticoids--interactions across 
many time scales. Mol Cell Endocrinol 380, 2-15. 
Dillon, R. J., Vennard, C. T., Charnley, A. K., 2000. Exploitation of gut bacteria in the locust. Nature 403, 
851. 
Dillon, R. J., Vennard, C. T., Charnley, A. K., 2002. A note: gut bacteria produce components of a locust 
cohesion pheromone. J Appl Microbiol 92, 759-763. 
Dinan, T. G., Cryan, J. F., 2013. Melancholic microbes: a link between gut microbiota and depression? 
Neurogastroenterol Motil 25, 713-719. 
Dinan, T. G., Cryan, J. F., 2017. Gut instincts: microbiota as a key regulator of brain development, ageing 
and neurodegeneration. J Physiol 595, 489-503. 
Dinan, T. G., Stilling, R. M., Stanton, C., Cryan, J. F., 2015. Collective unconscious: how gut microbes shape 
human behavior. J Psychiatr Res 63, 1-9. 
Ditzen, B., Schaer, M., Gabriel, B., Bodenmann, G., Ehlert, U., Heinrichs, M., 2009. Intranasal Oxytocin 
Increases Positive Communication and Reduces Cortisol Levels During Couple Conflict. Biol 
Psychiatry 65, 728-731. 
Dluzen, D. E., Muraoka, S., Engelmann, M., Ebner, K., Landgraf, R., 2000. Oxytocin induces preservation of 
social recognition in male rats by activating alpha-adrenoceptors of the olfactory bulb. Eur J Neurosci 
12, 760-766. 
Dluzen, D. E., Muraoka, S., Engelmann, M., Landgraf, R., 1998. The effects of infusion of arginine 
vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses 
in male rats. Peptides 19, 999-1005. 
Dölen, G., Darvishzadeh, A., Huang, K. W., Malenka, R. C., 2013. Social reward requires coordinated 
activity of nucleus accumbens oxytocin and serotonin. Nature 501, 179. 
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., Knight, R., 2010. 
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body 
habitats in newborns. Proc Natl Acad Sci U S A 107, 11971-11975. 
Donohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W., Bultman, S. J., 2012. The Warburg effect dictates 
the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 48, 612-
626. 
Duca, F. A., Swartz, T. D., Sakar, Y., Covasa, M., 2012. Increased oral detection, but decreased intestinal 
signaling for fats in mice lacking gut microbiota. PLoS One 7, e39748. 
Duerkop, B. A., Vaishnava, S., Hooper, L. V., 2009a. Immune Responses to the Microbiota at the Intestinal 
Mucosal Surface. Immunity 31, 368-376. 
Duerkop, B. A., Vaishnava, S., Hooper, L. V., 2009b. Immune responses to the microbiota at the intestinal 




Edelman, S. M., Kasper, D. L., 2008. Symbiotic commensal bacteria direct maturation of the host immune 
system. Curr Opin Gastroenterol 24, 720-724. 
Eisenegger, C., Haushofer, J., Fehr, E., 2011. The role of testosterone in social interaction. Trends in 
Cognitive Sciences 15, 263-271. 
El-Ansary, A. K., Ben Bacha, A., Kotb, M., 2012. Etiology of autistic features: the persisting neurotoxic 
effects of propionic acid. J Neuroinflammation 9, 74. 
Elliott, J. C., Lubin, D. A., Walker, C. H., Johns, J. M., 2001. Acute cocaine alters oxytocin levels in the 
medial preoptic area and amygdala in lactating rat dams: implications for cocaine-induced changes 
in maternal behavior and maternal aggression. Neuropeptides 35, 127-134. 
Engelmann, M., Ebner, K., Wotjak, C. T., Landgraf, R., 1998. Endogenous oxytocin is involved in short-term 
olfactory memory in female rats. Behav Brain Res 90, 89-94. 
Erdman, S. E., Poutahidis, T., 2016. Chapter Five - Microbes and Oxytocin: Benefits for Host Physiology 
and Behavior. In: Cryan, J. F., Clarke, G., (Eds), Int Rev Neurobiol. Academic Press, pp. 91-126. 
Erny, D., Hrabe de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., 
Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermohlen, O., Chun, E., Garrett, W. S., 
McCoy, K. D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I., Prinz, M., 2015. Host microbiota 
constantly control maturation and function of microglia in the CNS. Nat Neurosci 18, 965-977. 
Faa, G., Gerosa, C., Fanni, D., Nemolato, S., van Eyken, P., Fanos, V., 2013. Factors influencing the 
development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic 
therapy. J Matern Fetal Neonatal Med 26 Suppl 2, 35-43. 
Feldman, R., Weller, A., Zagoory-Sharon, O., Levine, A., 2007. Evidence for a neuroendocrinological 
foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period 
predict mother-infant bonding. Psychol Sci 18, 965-970. 
Festa, E. D., Russo, S. J., Gazi, F. M., Niyomchai, T., Kemen, L. M., Lin, S. N., Foltz, R., Jenab, S., Quinones-
Jenab, V., 2004. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and 
monoamine levels. Neuropharmacology 46, 672-687. 
Fetissov, S. O., 2017. Role of the gut microbiota in host appetite control: bacterial growth to animal 
feeding behaviour. Nat Rev Endocrinol 13, 11-25. 
Fetissov, S. O., Hamze Sinno, M., Coeffier, M., Bole-Feysot, C., Ducrotte, P., Hokfelt, T., Dechelotte, P., 
2008. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative 
modulation by gut microflora. Nutrition 24, 348-359. 
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. 
H., Granpeesheh, D., Dixon, D., Liu, M., Molitoris, D. R., Green, J. A., 3rd, 2010. Pyrosequencing study 
of fecal microflora of autistic and control children. Anaerobe 16, 444-453. 
Fitzgerald, P., Cassidy Eugene, M., Clarke, G., Scully, P., Barry, S., Quigley Eamonn, M. M., Shanahan, F., 
Cryan, J., Dinan Timothy, G., 2008. Tryptophan catabolism in females with irritable bowel syndrome: 
relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. 
Neurogastroenterol Motil 20, 1291-1297. 
Forssten, S. D., Korczynska, M. Z., Zwijsen, R. M., Noordman, W. H., Madetoja, M., Ouwehand, A. C., 2013. 
Changes in satiety hormone concentrations and feed intake in rats in response to lactic acid bacteria. 
Appetite 71, 16-21. 
Forsythe, P., Bienenstock, J., 2010. Immunomodulation by commensal and probiotic bacteria. Immunol 
Invest 39, 429-448. 
Foster, J. A., Rinaman, L., Cryan, J. F., 2017. Stress & the gut-brain axis: Regulation by the microbiome. 
Neurobiology of Stress. 
Frodl, T., O'Keane, V., 2013. How does the brain deal with cumulative stress? A review with focus on 
developmental stress, HPA axis function and hippocampal structure in humans. Neurobiology of 
Disease 52, 24-37. 
Frost, G., Brynes, A., Leeds, A., 1999. Effect of large bowel fermentation on insulin, glucose, free fatty 
acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease. Nutrition 15, 
183-188. 
Frost, G., Sleeth, M. L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., 




E., Bell, J. D., 2014. The short-chain fatty acid acetate reduces appetite via a central homeostatic 
mechanism. Nat Commun 5, 3611. 
Froy, O., 2010. Metabolism and Circadian Rhythms—Implications for Obesity. Endocrine Reviews 31, 1-24. 
Frye, C. A., Wawrzycki, J., 2003. Effect of prenatal stress and gonadal hormone condition on depressive 
behaviors of female and male rats. Hormones and Behavior 44, 319-326. 
Gareau, M. G., Wine, E., Rodrigues, D. M., Cho, J. H., Whary, M. T., Philpott, D. J., Macqueen, G., Sherman, 
P. M., 2011. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60, 307-317. 
Germain, N., Galusca, B., Le Roux, C. W., Bossu, C., Ghatei, M. A., Lang, F., Bloom, S. R., Estour, B., 2007. 
Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, 
glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr 85, 967-971. 
Gibson, G. R., Roberfroid, M. B., 1995. Dietary modulation of the human colonic microbiota: introducing 
the concept of prebiotics. J Nutr 125, 1401-1412. 
Glowa, J. R., Barrett, J. E., Russell, J., Gold, P. W., 1992. Effects of corticotropin releasing hormone on 
appetitive behaviors. Peptides 13, 609-621. 
Goeders, N. E., 1997. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22, 
237-259. 
Goeders, N. E., 2002. The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27, 13-33. 
Goehler, L. E., Gaykema, R. P., Hansen, M. K., Anderson, K., Maier, S. F., Watkins, L. R., 2000. Vagal 
immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci 85, 49-59. 
Goehler, L. E., Gaykema, R. P., Nguyen, K. T., Lee, J. E., Tilders, F. J., Maier, S. F., Watkins, L. R., 1999. 
Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and 
nervous systems? J Neurosci 19, 2799-2806. 
Goehler, L. E., Gaykema, R. P., Opitz, N., Reddaway, R., Badr, N., Lyte, M., 2005. Activation in vagal 
afferents and central autonomic pathways: early responses to intestinal infection with 
Campylobacter jejuni. Brain Behav Immun 19, 334-344. 
Goland, R. S., Wardlaw, S. L., MacCarter, G., Warren, W. B., Stark, R. I., 1991. Adrenocorticotropin and 
cortisol responses to vasopressin during pregnancy. J Clin Endocrinol Metab 73, 257-261. 
Golubeva, A. V., Crampton, S., Desbonnet, L., Edge, D., O'Sullivan, O., Lomasney, K. W., Zhdanov, A. V., 
Crispie, F., Moloney, R. D., Borre, Y. E., Cotter, P. D., Hyland, N. P., O'Halloran, K. D., Dinan, T. G., 
O'Keeffe, G. W., Cryan, J. F., 2015. Prenatal stress-induced alterations in major physiological systems 
correlate with gut microbiota composition in adulthood. Psychoneuroendocrinology 60, 58-74. 
Goodson, J. L., Bass, A. H., 2001. Social behavior functions and related anatomical characteristics of 
vasotocin/vasopressin systems in vertebrates. Brain Res Brain Res Rev 35, 246-265. 
Goyal, M. S., Venkatesh, S., Milbrandt, J., Gordon, J. I., Raichle, M. E., 2015. Feeding the brain and 
nurturing the mind: Linking nutrition and the gut microbiota to brain development. Proc Natl Acad 
Sci U S A 112, 14105-14112. 
Guo, F., Bakal, K., Minokoshi, Y., Hollenberg, A. N., 2004. Leptin Signaling Targets the Thyrotropin-
Releasing Hormone Gene Promoter in Vivo. Endocrinology 145, 2221-2227. 
Guo, G., Jia, K. R., Shi, Y., Liu, X. F., Liu, K. Y., Qi, W., Guo, Y., Zhang, W. J., Wang, T., Xiao, B., Zou, Q. M., 
2009. Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the 
BALB/c mouse. Stress 12, 478-485. 
Gur, T. L., Shay, L., Palkar, A. V., Fisher, S., Varaljay, V. A., Dowd, S., Bailey, M. T., 2017. Prenatal stress 
affects placental cytokines and neurotrophins, commensal microbes, and anxiety-like behavior in 
adult female offspring. Brain Behav Immun 64, 50-58. 
Hall, J., 2011. Guyton and Hall textbook of medical physiology Sanviers/Elsevier, Philadelphia. 
Hamady, M., Knight, R., 2009. Microbial community profiling for human microbiome projects: Tools, 
techniques, and challenges. Genome Res 19, 1141-1152. 
Harach, T., Marungruang, N., Dutilleul, N., Cheatham, V., Coy, K. D. M., Neher, J. J., Jucker, M., F£¿k, F., T., 
Lasser, Bolmont, T., 2015. Reduction of Alzheimer's disease beta-amyloid pathology in the absence 
of gut microbiota. Quantitative Biology. 
Harada, T., Nakahara, T., Yasuhara, D., Kojima, S., Sagiyama, K.-i., Amitani, H., Laviano, A., Naruo, T., Inui, 
A., 2008. Obestatin, Acyl Ghrelin, and Des-acyl Ghrelin Responses to an Oral Glucose Tolerance Test 




Hatton, G. I., 1988. Pituicytes, glia and control of terminal secretion. J Exp Biol 139, 67-79. 
Heinrichs, M., Baumgartner, T., Kirschbaum, C., Ehlert, U., 2003. Social support and oxytocin interact to 
suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54, 1389-1398. 
Heinrichs, M., von Dawans, B., Domes, G., 2009. Oxytocin, vasopressin, and human social behavior. 
Frontiers in Neuroendocrinology 30, 548-557. 
Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., Scheimann, J., Myers, B., 
2016. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comprehensive 
Physiology 6, 603-621. 
Hines, M., 2006. Prenatal testosterone and gender-related behaviour. Eur J Endocrinol 155 Suppl 1, S115-
121. 
Hines, M., Constantinescu, M., Spencer, D., 2015. Early androgen exposure and human gender 
development. Biology of Sex Differences 6, 3. 
Hoban, A. E., Stilling, R. M., Moloney, G., Shanahan, F., Dinan, T. G., Clarke, G., Cryan, J. F., 2017. The 
microbiome regulates amygdala-dependent fear recall. Mol Psychiatry. 
Hoge, E. A., Pollack, M. H., Kaufman, R. E., Zak, P. J., Simon, N. M., 2008. Oxytocin levels in social anxiety 
disorder. CNS Neurosci Ther 14, 165-170. 
Holzer, P., Reichmann, F., Farzi, A., 2012. Neuropeptide Y, peptide YY and pancreatic polypeptide in the 
gut-brain axis. Neuropeptides 46, 261-274. 
Hotta, M., Shibasaki, T., Masuda, A., Imaki, T., Demura, H., Ling, N., Shizume, K., 1986. The Responses of 
Plasma Adrenocorticotropin and Cortisol to Corticotropin-Releasing Hormone (CRH) and 
Cerebrospinal Fluid Immunoreactive CRH in Anorexia Nervosa Patients*. The Journal of Clinical 
Endocrinology & Metabolism 62, 319-324. 
Hsiao, E. Y., 2013. Immune dysregulation in autism spectrum disorder. Int Rev Neurobiol 113, 269-302. 
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, 
S. E., Petrosino, J. F., Patterson, P. H., Mazmanian, S. K., 2013. Microbiota modulate behavioral and 
physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463. 
Huang, B. M., Leu, S. F., Yang, H. Y., Norman, R. L., 2001. Testosterone effects on luteinizing hormone and 
follicle-stimulating hormone responses to gonadotropin-releasing hormone in the mouse. J Androl 
22, 507-513. 
Hui, G. K., Figueroa, I. R., Poytress, B. S., Roozendaal, B., McGaugh, J. L., Weinberger, N. M., 2004. 
Memory enhancement of classical fear conditioning by post-training injections of corticosterone in 
rats. Neurobiology of Learning and Memory 81, 67-74. 
Huuskonen, J., Suuronen, T., Nuutinen, T., Kyrylenko, S., Salminen, A., 2004. Regulation of microglial 
inflammatory response by sodium butyrate and short-chain fatty acids. Br J Pharmacol 141, 874-880. 
Ibragimov, R. S., 1990. Influence of neurohypophyseal peptides on the formation of active avoidance 
conditioned reflex behavior. Neuroscience and Behavioral Physiology 20, 189-193. 
Jacob, S., Brune, C. W., Carter, C. S., Leventhal, B. L., Lord, C., Cook, E. H., Jr., 2007. Association of the 
oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci Lett 417, 
6-9. 
Jang, S. E., Lim, S. M., Jeong, J. J., Jang, H. M., Lee, H. J., Han, M. J., Kim, D. H., 2017. Gastrointestinal 
inflammation by gut microbiota disturbance induces memory impairment in mice. Mucosal 
Immunol. 
Jansen, A. S., Nguyen, X. V., Karpitskiy, V., Mettenleiter, T. C., Loewy, A. D., 1995. Central command 
neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 270, 644-
646. 
Jašarević, E., Howard, C. D., Misic, A. M., Beiting, D. P., Bale, T. L., 2017. Stress during pregnancy alters 
temporal and spatial dynamics of the maternal and offspring microbiome in a sex-specific manner. 
Sci Rep 7. 
Joffe, R. T., Sokolov, S. T., 1994. Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 
8, 45-63. 
Johns, J. M., Lubin, D. A., Walker, C. H., Meter, K. E., Mason, G. A., 1997. Chronic gestational cocaine 
treatment decreases oxytocin levels in the medial preoptic area, ventral tegmental area and 




Kang, D. W., Park, J. G., Ilhan, Z. E., Wallstrom, G., Labaer, J., Adams, J. B., Krajmalnik-Brown, R., 2013. 
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. 
PLoS One 8, e68322. 
Karlson, P., Luscher, M., 1959. Pheromones': a new term for a class of biologically active substances. 
Nature 183, 55-56. 
Kaye, W. H., Fudge, J. L., Paulus, M., 2009. New insights into symptoms and neurocircuit function of 
anorexia nervosa. Nat Rev Neurosci 10, 573-584. 
Kekuda, R., Manoharan, P., Baseler, W., Sundaram, U., 2013. Monocarboxylate 4 mediated butyrate 
transport in a rat intestinal epithelial cell line. Dig Dis Sci 58, 660-667. 
Kelly, J. R., Borre, Y., C, O. B., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., 
Moloney, G., Hoban, A. E., Scott, L., Fitzgerald, P., Ross, P., Stanton, C., Clarke, G., Cryan, J. F., Dinan, 
T. G., 2016. Transferring the blues: Depression-associated gut microbiota induces neurobehavioural 
changes in the rat. J Psychiatr Res 82, 109-118. 
Kim, S., Kim, H., Yim, Y. S., Ha, S., Atarashi, K., Tan, T. G., Longman, R. S., Honda, K., Littman, D. R., Choi, G. 
B., Huh, J. R., 2017. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse 
offspring. Nature advance online publication. 
Kiraly, D. D., Walker, D. M., Calipari, E. S., Labonte, B., Issler, O., Pena, C. J., Ribeiro, E. A., Russo, S. J., 
Nestler, E. J., 2016. Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine. Sci 
Rep 6, 35455. 
Klarer, M., Arnold, M., Gunther, L., Winter, C., Langhans, W., Meyer, U., 2014. Gut vagal afferents 
differentially modulate innate anxiety and learned fear. J Neurosci 34, 7067-7076. 
Kleiman, S. C., Watson, H. J., Bulik-Sullivan, E. C., Huh, E. Y., Tarantino, L. M., Bulik, C. M., Carroll, I. M., 
2015. The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship 
to Depression, Anxiety, and Eating Disorder Psychopathology. Psychosom Med 77, 969-981. 
Klosterbuer, A. S., Thomas, W., Slavin, J. L., 2012. Resistant starch and pullulan reduce postprandial 
glucose, insulin, and GLP-1, but have no effect on satiety in healthy humans. J Agric Food Chem 60, 
11928-11934. 
Koch, H., Schmid-Hempel, P., 2011. Socially transmitted gut microbiota protect bumble bees against an 
intestinal parasite. Proc Natl Acad Sci U S A 108, 19288-19292. 
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T., Ley, R. E., 
2011. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci 
U S A 108 Suppl 1, 4578-4585. 
Kohsaka, A., Laposky, A. D., Ramsey, K. M., Estrada, C., Joshu, C., Kobayashi, Y., Turek, F. W., Bass, J., 2007. 
High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 6, 414-421. 
Koob, G. F., 2010. The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314, 
3-14. 
Kosten, T. A., Ambrosio, E., 2002. HPA axis function and drug addictive behaviors: insights from studies 
with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27, 35-69. 
Krahn, D. D., Gosnell, B. A., Levine, A. S., Morley, J. E., 1988. Behavioral effects of corticotropin-releasing 
factor: localization and characterization of central effects. Brain Research 443, 63-69. 
Kruh, J., 1982. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell 
Biochem 42, 65-82. 
Kudielka, B. M., Buske-Kirschbaum, A., Hellhammer, D. H., Kirschbaum, C., 2004. HPA axis responses to 
laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age 
and gender. Psychoneuroendocrinology 29, 83-98. 
Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toyoda, A., Takami, H., Morita, H., Sharma, V. K., 
Srivastava, T. P., Taylor, T. D., Noguchi, H., Mori, H., Ogura, Y., Ehrlich, D. S., Itoh, K., Takagi, T., 
Sakaki, Y., Hayashi, T., Hattori, M., 2007. Comparative metagenomics revealed commonly enriched 
gene sets in human gut microbiomes. DNA Res 14, 169-181. 
Lach, G., Schellekens, H., Dinan, T. G., Cryan, J. F., 2017. Anxiety, Depression, and the Microbiome: A Role 




Lawson, E. A., Donoho, D. A., Blum, J. I., Meenaghan, E. M., Misra, M., Herzog, D. B., Sluss, P. M., Miller, K. 
K., Klibanski, A., 2011. Decreased nocturnal oxytocin levels in anorexia nervosa are associated with 
low bone mineral density and fat mass. J Clin Psychiatry 72, 1546-1551. 
Lawson, E. A., Holsen, L. M., Santin, M., Meenaghan, E., Eddy, K. T., Becker, A. E., Herzog, D. B., Goldstein, 
J. M., Klibanski, A., 2012. Oxytocin Secretion Is Associated with Severity of Disordered Eating 
Psychopathology and Insular Cortex Hypoactivation in Anorexia Nervosa. The Journal of Clinical 
Endocrinology & Metabolism 97, E1898-E1908. 
Lawson, E. A., Marengi, D. A., DeSanti, R. L., Holmes, T. M., Schoenfeld, D. A., Tolley, C. J., 2015. Oxytocin 
reduces caloric intake in men. Obesity 23, 950-956. 
Le, A. D., Harding, S., Juzytsch, W., Watchus, J., Shalev, U., Shaham, Y., 2000. The role of corticotrophin-
releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology 
(Berl) 150, 317-324. 
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, 
J. M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jorgensen, T., Brandslund, I., Nielsen, 
H. B., Juncker, A. S., Bertalan, M., Levenez, F., Pons, N., Rasmussen, S., Sunagawa, S., Tap, J., Tims, S., 
Zoetendal, E. G., Brunak, S., Clement, K., Dore, J., Kleerebezem, M., Kristiansen, K., Renault, P., 
Sicheritz-Ponten, T., de Vos, W. M., Zucker, J. D., Raes, J., Hansen, T., Bork, P., Wang, J., Ehrlich, S. D., 
Pedersen, O., 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 
500, 541-546. 
Leclercq, S., Matamoros, S., Cani, P. D., Neyrinck, A. M., Jamar, F., Starkel, P., Windey, K., Tremaroli, V., 
Backhed, F., Verbeke, K., de Timary, P., Delzenne, N. M., 2014. Intestinal permeability, gut-bacterial 
dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A 111, 
E4485-4493. 
Lee, M. R., Rohn, M. C., Tanda, G., Leggio, L., 2016. Targeting the Oxytocin System to Treat Addictive 
Disorders: Rationale and Progress to Date. CNS Drugs 30, 109-123. 
Lee, S. A., Lim, J. Y., Kim, B. S., Cho, S. J., Kim, N. Y., Kim, O. B., Kim, Y., 2015. Comparison of the gut 
microbiota profile in breast-fed and formula-fed Korean infants using pyrosequencing. Nutr Res 
Pract 9, 242-248. 
Lehmann, J., Russig, H., Feldon, J., Pryce, C. R., 2002. Effect of a single maternal separation at different 
pup ages on the corticosterone stress response in adult and aged rats. Pharmacol Biochem Behav 73, 
141-145. 
Leitao-Goncalves, R., Carvalho-Santos, Z., Francisco, A. P., Fioreze, G. T., Anjos, M., Baltazar, C., Elias, A. P., 
Itskov, P. M., Piper, M. D. W., Ribeiro, C., 2017. Commensal bacteria and essential amino acids 
control food choice behavior and reproduction. PLoS Biol 15, e2000862. 
Leonard, B. E., 2005. The HPA and immune axes in stress: The involvement of the serotonergic system. 
European Psychiatry 20, S302-S306. 
Leone, V., Gibbons, S. M., Martinez, K., Hutchison, A. L., Huang, E. Y., Cham, C. M., Pierre, J. F., Heneghan, 
A. F., Nadimpalli, A., Hubert, N., Zale, E., Wang, Y., Huang, Y., Theriault, B., Dinner, A. R., Musch, M. 
W., Kudsk, K. A., Prendergast, B. J., Gilbert, J. A., Chang, E. B., 2015. Effects of diurnal variation of gut 
microbes and high-fat feeding on host circadian clock function and metabolism. Cell Host Microbe 
17, 681-689. 
Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., Gordon, J. I., 2005. Obesity alters gut 
microbial ecology. Proc Natl Acad Sci U S A 102, 11070-11075. 
Ley, R. E., Turnbaugh, P. J., Klein, S., Gordon, J. I., 2006. Microbial ecology: human gut microbes 
associated with obesity. Nature 444, 1022-1023. 
Li, W., Dowd, S. E., Scurlock, B., Acosta-Martinez, V., Lyte, M., 2009. Memory and learning behavior in 
mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 96, 557-
567. 
Liang, X., Bushman, F. D., FitzGerald, G. A., 2015. Rhythmicity of the intestinal microbiota is regulated by 
gender and the host circadian clock. Proc Natl Acad Sci U S A 112, 10479-10484. 
Linnen, A. M., Ellenbogen, M. A., Cardoso, C., Joober, R., 2012. Intranasal oxytocin and salivary cortisol 




Lize, A., McKay, R., Lewis, Z., 2014. Kin recognition in Drosophila: the importance of ecology and gut 
microbiota. Isme j 8, 469-477. 
Lombardo, M. P., 2008. Access to mutualistic endosymbiotic microbes: an underappreciated benefit of 
group living Behavioural Ecology and Sociobiology 62, 479-497. 
Luoto, R., Kalliomaki, M., Laitinen, K., Isolauri, E., 2010. The impact of perinatal probiotic intervention on 
the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes 
(Lond) 34, 1531-1537. 
Lupien, S. J., Maheu, F., Tu, M., Fiocco, A., Schramek, T. E., 2007. The effects of stress and stress 
hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn 65, 209-
237. 
Lyte, M., 2014. Microbial endocrinology: Host-microbiota neuroendocrine interactions influencing brain 
and behavior. Gut Microbes 5, 381-389. 
Ma, S., Shipston, M. J., Morilak, D., Russell, J. A., 2005. Reduced hypothalamic vasopressin secretion 
underlies attenuated adrenocorticotropin stress responses in pregnant rats. Endocrinology 146, 
1626-1637. 
Maccari, S., Darnaudery, M., Morley-Fletcher, S., Zuena, A. R., Cinque, C., Van Reeth, O., 2003. Prenatal 
stress and long-term consequences: implications of glucocorticoid hormones. Neuroscience & 
Biobehavioral Reviews 27, 119-127. 
Macfarlane, G. T., Macfarlane, S., 2012. Bacteria, Colonic Fermentation, and Gastrointestinal Health. 
Journal of AOAC International 95, 50-60. 
Mack, I., Cuntz, U., Grämer, C., Niedermaier, S., Pohl, C., Schwiertz, A., Zimmermann, K., Zipfel, S., Enck, 
P., Penders, J., 2016. Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, 
branched chain fatty acid profiles, and gastrointestinal complaints. Sci Rep 6. 
Maes, M., Kubera, M., Leunis, J. C., 2008. The gut-brain barrier in major depression: intestinal mucosal 
dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) 
plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29, 117-124. 
Maniscalco, J. W., Rinaman, L., 2018. Vagal Interoceptive Modulation of Motivated Behavior. Physiology 
33, 151-167. 
Mantsch, J. R., Cullinan, W. E., Tang, L. C., Baker, D. A., Katz, E. S., Hoks, M. A., Ziegler, D. R., 2007a. Daily 
cocaine self-administration under long-access conditions augments restraint-induced increases in 
plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats. Brain 
Research 1167, 101-111. 
Mantsch, J. R., Taves, S., Khan, T., Katz, E. S., Sajan, T., Tang, L. C., Cullinan, W. E., Ziegler, D. R., 2007b. 
Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented 
during acute withdrawal from chronic cocaine administration. Neurosci Lett 415, 269-273. 
Marazziti, D., Dell'Osso, B., Baroni, S., Mungai, F., Catena, M., Rucci, P., Albanese, F., Giannaccini, G., Betti, 
L., Fabbrini, L., Italiani, P., Del Debbio, A., Lucacchini, A., Dell'Osso, L., 2006. A relationship between 
oxytocin and anxiety of romantic attachment. Clin Pract Epidemiol Ment Health 2, 28. 
Mariotti, S., Beck-Peccoz, P., 2000. Physiology of the Hypothalamic-Pituitary-Thyroid Axis. In: De Groot, L. 
J., Chrousos, G., Dungan, K., Feingold, K. R., Grossman, A., Hershman, J. M., Koch, C., Korbonits, M., 
McLachlan, R., New, M., Purnell, J., Rebar, R., Singer, F., Vinik, A., (Eds), Endotext. MDText.com, Inc., 
South Dartmouth (MA). 
Marques, T. M., Wall, R., Ross, R. P., Fitzgerald, G. F., Ryan, C. A., Stanton, C., 2010. Programming infant 
gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 21, 149-156. 
Marvel, F. A., Chen, C. C., Badr, N., Gaykema, R. P., Goehler, L. E., 2004. Reversible inactivation of the 
dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in 
central autonomic nuclei. Brain Behav Immun 18, 123-134. 
Matis, G., Neogrady, Z., Csiko, G., Kulcsar, A., Kenez, A., Huber, K., 2013. Effects of orally applied butyrate 
bolus on histone acetylation and cytochrome P450 enzyme activity in the liver of chicken - a 
randomized controlled trial. Nutr Metab (Lond) 10, 12. 
Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Sawaki, E., Koga, Y., Benno, Y., 2013. Cerebral low-molecular 
metabolites influenced by intestinal microbiota: a pilot study. Front Syst Neurosci 7, 9. 




McCall, C., Singer, T., 2012. The animal and human neuroendocrinology of social cognition, motivation 
and behavior. Nat Neurosci 15, 681. 
McEwen, B. S., 2007. Physiology and neurobiology of stress and adaptation: central role of the brain. 
Physiol Rev 87, 873-904. 
McEwen, B. S., Gray, J. D., Nasca, C., 2015. 60 YEARS OF NEUROENDOCRINOLOGY: Redefining 
neuroendocrinology: stress, sex and cognitive and emotional regulation. J Endocrinol 226, T67-83. 
McEwen, B. S., Sapolsky, R. M., 1995. Stress and cognitive function. Current Opinion in Neurobiology 5, 
205-216. 
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., Crawley, J. N., 2008. Autism-like 
behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav 7, 152-163. 
McGregor, I. S., Bowen, M. T., 2012. Breaking the loop: oxytocin as a potential treatment for drug 
addiction. Horm Behav 61, 331-339. 
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J. F., Rougeot, C., Pichelin, 
M., Cazaubiel, M., Cazaubiel, J. M., 2011. Assessment of psychotropic-like properties of a probiotic 
formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human 
subjects. Br J Nutr 105, 755-764. 
Meyer-Lindenberg, A., Domes, G., Kirsch, P., Heinrichs, M., 2011. Oxytocin and vasopressin in the human 
brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12, 524-538. 
Million, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B., Raoult, D., 2013. 
Correlation between body mass index and gut concentrations of Lactobacillus reuteri, 
Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int J Obes (Lond) 37, 
1460-1466. 
Minter, M. R., Zhang, C., Leone, V., Ringus, D. L., Zhang, X., Oyler-Castrillo, P., Musch, M. W., Liao, F., 
Ward, J. F., Holtzman, D. M., Chang, E. B., Tanzi, R. E., Sisodia, S. S., 2016. Antibiotic-induced 
perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine 
model of Alzheimer's disease. Sci Rep 6, 30028. 
Mohler, H., 2012. The GABA system in anxiety and depression and its therapeutic potential. 
Neuropharmacology 62, 42-53. 
Molnar, J., 1988. Antiplasmid activity of tricyclic compounds. Methods Find Exp Clin Pharmacol 10, 467-
474. 
Moloney, R. D., Desbonnet, L., Clarke, G., Dinan, T. G., Cryan, J. F., 2014. The microbiome: stress, health 
and disease. Mamm Genome 25, 49-74. 
Monteleone, P., Bortolotti, F., Fabrazzo, M., La Rocca, A., Fuschino, A., Maj, M., 2000. Plasma Leptin 
Response to Acute Fasting and Refeeding in Untreated Women with Bulimia Nervosa. The Journal of 
Clinical Endocrinology & Metabolism 85, 2499-2503. 
Monteleone, P., Serritella, C., Martiadis, V., Maj, M., 2008. Deranged Secretion of Ghrelin and Obestatin 
in the Cephalic Phase of Vagal Stimulation in Women with Anorexia Nervosa. Biol Psychiatry 64, 
1005-1008. 
Montiel-Castro, A. J., Gonzalez-Cervantes, R. M., Bravo-Ruiseco, G., Pacheco-Lopez, G., 2013. The 
microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci 7, 
70. 
Moreira, A. P., Texeira, T. F., Ferreira, A. B., Peluzio Mdo, C., Alfenas Rde, C., 2012. Influence of a high-fat 
diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108, 801-809. 
Morita, C., Tsuji, H., Hata, T., Gondo, M., Takakura, S., Kawai, K., Yoshihara, K., Ogata, K., Nomoto, K., 
Miyazaki, K., Sudo, N., 2015. Gut Dysbiosis in Patients with Anorexia Nervosa. PLoS One 10. 
Morley-Fletcher, S., Darnaudery, M., Koehl, M., Casolini, P., Van Reeth, O., Maccari, S., 2003. Prenatal 
stress in rats predicts immobility behavior in the forced swim test. Brain Research 989, 246-251. 
Mouihate, A., Galic, M. A., Ellis, S. L., Spencer, S. J., Tsutsui, S., Pittman, Q. J., 2010. Early life activation of 
toll-like receptor 4 reprograms neural anti-inflammatory pathways. J Neurosci 30, 7975-7983. 
Mueller, B. R., Bale, T. L., 2008. Sex-specific programming of offspring emotionality after stress early in 
pregnancy. J Neurosci 28, 9055-9065. 
Mukherji, A., Kobiita, A., Ye, T., Chambon, P., 2013. Homeostasis in intestinal epithelium is orchestrated 




Munoz-Bellido, J. L., Munoz-Criado, S., Garcia-Rodriguez, J. A., 1996. In-vitro activity of psychiatric drugs 
against Corynebacterium urealyticum (Corynebacterium group D2). J Antimicrob Chemother 37, 
1005-1009. 
Munoz-Bellido, J. L., Munoz-Criado, S., Garcia-Rodriguez, J. A., 2000. Antimicrobial activity of psychotropic 
drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents 14, 177-180. 
Murray, S., Tulloch, A., Gold, M. S., Avena, N. M., 2014. Hormonal and neural mechanisms of food reward, 
eating behaviour and obesity. Nature Reviews Endocrinology 10, 540. 
Mutlu, E., Keshavarzian, A., Engen, P., Forsyth, C. B., Sikaroodi, M., Gillevet, P., 2009. Intestinal dysbiosis: 
a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol 
Clin Exp Res 33, 1836-1846. 
Mutlu, E. A., Gillevet, P. M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P. A., Kwasny, M., Lau, C. K., 
Keshavarzian, A., 2012. Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver 
Physiol 302, G966-978. 
Nakahara, T., Kojima, S., Tanaka, M., Yasuhara, D., Harada, T., Sagiyama, K., Muranaga, T., Nagai, N., 
Nakazato, M., Nozoe, S., Naruo, T., Inui, A., 2007. Incomplete restoration of the secretion of ghrelin 
and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J 
Psychiatr Res 41, 814-820. 
Nankova, B. B., Agarwal, R., MacFabe, D. F., La Gamma, E. F., 2014. Enteric bacterial metabolites propionic 
and butyric acid modulate gene expression, including CREB-dependent catecholaminergic 
neurotransmission, in PC12 cells--possible relevance to autism spectrum disorders. PLoS One 9, 
e103740. 
Naukkarinen, J., Rissanen, A., Kaprio, J., Pietilainen, K. H., 2012. Causes and consequences of obesity: the 
contribution of recent twin studies. Int J Obes (Lond) 36, 1017-1024. 
Nemeroff, C. B., 2002. Recent advances in the neurobiology of depression. Psychopharmacology bulletin 
36 Suppl 2, 6-23. 
Neufeld, K. M., Kang, N., Bienenstock, J., Foster, J. A., 2011. Reduced anxiety-like behavior and central 
neurochemical change in germ-free mice. Neurogastroenterol Motil 23, 255-264, e119. 
Neumann, I. D., Krömer, S. A., Toschi, N., Ebner, K., 2000. Brain oxytocin inhibits the (re)activity of the 
hypothalamo–pituitary–adrenal axis in male rats: involvement of hypothalamic and limbic brain 
regions. Regulatory Peptides 96, 31-38. 
Neumann, I. D., Slattery, D. A., 2016. Oxytocin in General Anxiety and Social Fear: A Translational 
Approach. Biol Psychiatry 79, 213-221. 
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., Pettersson, S., 2012. Host-gut 
microbiota metabolic interactions. Science 336, 1262-1267. 
NIH, 2017. https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-asd/index.shtml. 
Nilsson, A., Johansson, E., Ekstrom, L., Bjorck, I., 2013. Effects of a brown beans evening meal on 
metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a 
randomized cross-over study. PLoS One 8, e59985. 
Nisha Vijay, M. E. M., 2015. Role of Monocarboxylate Transporters in Drug Delivery to the Brain. Curr 
Pharm Des 20, 1487-1498. 
Nishino, R., Mikami, K., Takahashi, H., Tomonaga, S., Furuse, M., Hiramoto, T., Aiba, Y., Koga, Y., Sudo, N., 
2013. Commensal microbiota modulate murine behaviors in a strictly contamination-free 
environment confirmed by culture-based methods. Neurogastroenterol Motil 25, 521-528. 
Nohr, M. K., Pedersen, M. H., Gille, A., Egerod, K. L., Engelstoft, M. S., Husted, A. S., Sichlau, R. M., 
Grunddal, K. V., Poulsen, S. S., Han, S., Jones, R. M., Offermanns, S., Schwartz, T. W., 2013. 
GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs 
FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154, 3552-3564. 
Norman, G. J., Cacioppo, J. T., Morris, J. S., Malarkey, W. B., Berntson, G. G., DeVries, A. C., 2011. Oxytocin 
increases autonomic cardiac control: Moderation by loneliness. Biological Psychology 86, 174-180. 
Norris, V., Molina, F., Gewirtz, A. T., 2013. Hypothesis: bacteria control host appetites. J Bacteriol 195, 
411-416. 
O'Callaghan, M. J., Croft, A. P., Jacquot, C., Little, H. J., 2005. The hypothalamopituitary-adrenal axis and 




O'Mahony, S. M., Hyland, N. P., Dinan, T. G., Cryan, J. F., 2011. Maternal separation as a model of brain-
gut axis dysfunction. Psychopharmacology (Berl) 214, 71-88. 
O'Mahony, S. M., Marchesi, J. R., Scully, P., Codling, C., Ceolho, A. M., Quigley, E. M., Cryan, J. F., Dinan, T. 
G., 2009. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable 
bowel syndrome and psychiatric illnesses. Biol Psychiatry 65, 263-267. 
Oitzl, M. S., Fluttert, M., Sutanto, W., De Kloet, E. R., 1998. Continuous blockade of brain glucocorticoid 
receptors facilitates spatial learning and memory in rats. European Journal of Neuroscience 10, 
3759-3766. 
Onaka, T., 2004. Neural pathways controlling central and peripheral oxytocin release during stress. J 
Neuroendocrinol 16, 308-312. 
Owens, M. J., Nemeroff, C. B., 1994. Role of serotonin in the pathophysiology of depression: focus on the 
serotonin transporter. Clinical Chemistry 40, 288-295. 
Parnell, J. A., Reimer, R. A., 2009. Weight loss during oligofructose supplementation is associated with 
decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89, 1751-
1759. 
Parracho, H. M., Bingham, M. O., Gibson, G. R., McCartney, A. L., 2005. Differences between the gut 
microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 
54, 987-991. 
Paton, W. D. M., Vizi, E. S., Zar, M. A., 1971. The mechanism of acetylcholine release from 
parasympathetic nerves. J Physiol 215, 819-848. 
Peterson, V. L., Jury, N. J., Cabrera-Rubio, R., Draper, L. A., Crispie, F., Cotter, P. D., Dinan, T. G., Holmes, 
A., Cryan, J. F., 2017. Drunk bugs: Chronic vapour alcohol exposure induces marked changes in the 
gut microbiome in mice. Behav Brain Res 323, 172-176. 
Pfaff, D. W., Rapin, I., Goldman, S., 2011. Male predominance in autism: neuroendocrine influences on 
arousal and social anxiety. Autism Res 4, 163-176. 
Phelps, C., 2007. The Posterior Pituitary and its Hormones. xPharm: The Comprehensive Pharmacology 
Reference. Elsevier, New York, pp. 1-6. 
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., Fedele, E., Sancesario, G., 
Bernardi, G., Bergamaschi, A., Magrini, A., Stanzione, P., Galante, A., 2006. Helicobacter pylori 
eradication and l-dopa absorption in patients with PD and motor fluctuations. Neurology 66, 1824-
1829. 
Plant, T. M., 2015. The hypothalamo-pituitary-gonadal axis. J Endocrinol 226, T41-T54. 
Plotsky, P. M., Thrivikraman, K. V., Nemeroff, C. B., Caldji, C., Sharma, S., Meaney, M. J., 2005. Long-term 
consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat 
offspring. Neuropsychopharmacology 30, 2192-2204. 
Polter, A. M., Kauer, J. A., 2014. Stress and VTA synapses: implications for addiction and depression. Eur J 
Neurosci 39, 1179-1188. 
Poutahidis, T., Kearney, S. M., Levkovich, T., Qi, P., Varian, B. J., Lakritz, J. R., Ibrahim, Y. M., Chatzigiagkos, 
A., Alm, E. J., Erdman, S. E., 2013. Microbial symbionts accelerate wound healing via the 
neuropeptide hormone oxytocin. PLoS One 8, e78898. 
Poutahidis, T., Springer, A., Levkovich, T., Qi, P., Varian, B. J., Lakritz, J. R., Ibrahim, Y. M., Chatzigiagkos, 
A., Alm, E. J., Erdman, S. E., 2014. Probiotic Microbes Sustain Youthful Serum Testosterone Levels 
and Testicular Size in Aging Mice. PLoS One 9. 
Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., 
Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, 
J., Lepage, P., Bertalan, M., Batto, J.-M., Hansen, T., Le Paslier, D., Linneberg, A., Nielsen, H. B., 
Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., 
Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, 
O., Parkhill, J., Weissenbach, J., Bork, P., Ehrlich, S. D., Wang, J., 2010a. A human gut microbial gene 
catalogue established by metagenomic sequencing. Nature 464, 59-65. 
Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., 
Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, 




Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., 
Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, 
O., Parkhill, J., Weissenbach, J., Bork, P., Ehrlich, S. D., Wang, J., 2010b. A human gut microbial gene 
catalogue established by metagenomic sequencing. Nature 464, 59-65. 
Queipo-Ortuno, M. I., Seoane, L. M., Murri, M., Pardo, M., Gomez-Zumaquero, J. M., Cardona, F., 
Casanueva, F., Tinahones, F. J., 2013. Gut microbiota composition in male rat models under different 
nutritional status and physical activity and its association with serum leptin and ghrelin levels. PLoS 
One 8, e65465. 
Rabot, S., Membrez, M., Blancher, F., Berger, B., Moine, D., Krause, L., Bibiloni, R., Bruneau, A., Gerard, P., 
Siddharth, J., Lauber, C. L., Chou, C. J., 2016. High fat diet drives obesity regardless the composition 
of gut microbiota in mice. Sci Rep 6, 32484. 
Ravussin, Y., Koren, O., Spor, A., LeDuc, C., Gutman, R., Stombaugh, J., Knight, R., Ley, R. E., Leibel, R. L., 
2012. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. 
Obesity (Silver Spring) 20, 738-747. 
Raybould, H. E., 2010a. Gut chemosensing: Interactions between gut endocrine cells and visceral 
afferents. Autonomic Neuroscience 153, 41-46. 
Raybould, H. E., 2010b. Gut chemosensing: interactions between gut endocrine cells and visceral 
afferents. Auton Neurosci 153, 41-46. 
Rehfeld, J. F., 2004. A centenary of gastrointestinal endocrinology. Horm Metab Res 36, 735-741. 
Rhee, S. H., Pothoulakis, C., Mayer, E. A., 2009. Principles and clinical implications of the brain-gut-enteric 
microbiota axis. Nat Rev Gastroenterol Hepatol 6, 306-314. 
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., 
Henrissat, B., Bain, J. R., Muehlbauer, M. J., Ilkayeva, O., Semenkovich, C. F., Funai, K., Hayashi, D. K., 
Lyle, B. J., Martini, M. C., Ursell, L. K., Clemente, J. C., Van Treuren, W., Walters, W. A., Knight, R., 
Newgard, C. B., Heath, A. C., Gordon, J. I., 2013. Gut microbiota from twins discordant for obesity 
modulate metabolism in mice. Science 341, 1241214. 
Robertson, M. D., 2012. Dietary-resistant starch and glucose metabolism. Curr Opin Clin Nutr Metab Care 
15, 362-367. 
Rooks, M. G., Garrett, W. S., 2016. Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16, 
341-352. 
Roozendaal, B., McGaugh, J. L., 1997. Glucocorticoid Receptor Agonist and Antagonist Administration into 
the Basolateral but Not Central Amygdala Modulates Memory Storage. Neurobiology of Learning 
and Memory 67, 176-179. 
Roshchina, V. V., 2016. New Trends and Perspectives in the Evolution of Neurotransmitters in Microbial, 
Plant, and Animal Cells. Adv Exp Med Biol 874, 25-77. 
Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A., Lowry, C. A., 2006. Tryptophan 
metabolism in the central nervous system: medical implications. Expert Rev Mol Med 8, 1-27. 
Salama, A., Facer, C. A., 1990. Desipramine reversal of chloroquine resistance in wild isolates of 
Plasmodium falciparum. Lancet 335, 164-165. 
Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., Ngom-Bru, C., Berger, 
B., Philippe, L., Ammon-Zuffrey, C., Leone, P., Chevrier, G., St-Amand, E., Marette, A., Dore, J., 
Tremblay, A., 2014. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss 
and maintenance in obese men and women. Br J Nutr 111, 1507-1519. 
Sands, J. M., Blount, M. A., Klein, J. D., 2011. Regulation of renal urea transport by vasopressin. Trans Am 
Clin Climatol Assoc 122, 82-92. 
Sapolsky, R. M., 1996. Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of 
Confusion. Stress 1, 1-19. 
Sapolsky, R. M., Krey, L. C., McEwen, B. S., 1984. Glucocorticoid-sensitive hippocampal neurons are 
involved in terminating the adrenocortical stress response. Proceedings of the National Academy of 
Sciences 81, 6174-6177. 
Sarnyai, Z., Shaham, Y., Heinrichs, S. C., 2001. The role of corticotropin-releasing factor in drug addiction. 




Sarnyai, Z., Vecsernyes, M., Laczi, F., Biro, E., Szabo, G., Kovacs, G. L., 1992. Effects of cocaine on the 
contents of neurohypophyseal hormones in the plasma and in different brain structures in rats. 
Neuropeptides 23, 27-31. 
Schmidt, K., Cowen, P. J., Harmer, C. J., Tzortzis, G., Errington, S., Burnet, P. W., 2015. Prebiotic intake 
reduces the waking cortisol response and alters emotional bias in healthy volunteers. 
Psychopharmacology (Berl) 232, 1793-1801. 
Schroeder, F. A., Lin, C. L., Crusio, W. E., Akbarian, S., 2007. Antidepressant-like effects of the histone 
deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62, 55-64. 
Schwarcz, R., Bruno, J. P., Muchowski, P. J., Wu, H. Q., 2012. Kynurenines in the mammalian brain: when 
physiology meets pathology. Nat Rev Neurosci 13, 465-477. 
Scott, F. I., Horton, D. B., Mamtani, R., Haynes, K., Goldberg, D. S., Lee, D. Y., Lewis, J. D., 2016. 
Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity. 
Gastroenterology 151, 120-129.e125. 
Scott, K. A., Ida, M., Peterson, V. L., Prenderville, J. A., Moloney, G. M., Izumo, T., Murphy, K., Murphy, A., 
Ross, R. P., Stanton, C., Dinan, T. G., Cryan, J. F., 2017. Revisiting Metchnikoff: Age-related alterations 
in microbiota-gut-brain axis in the mouse. Brain Behav Immun 65, 20-32. 
Shaham, Y., Funk, D., Erb, S., Brown, T. J., Walker, C. D., Stewart, J., 1997. Corticotropin-releasing factor, 
but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17, 
2605-2614. 
Shanks, N., Larocque, S., Meaney, M. J., 1995. Neonatal endotoxin exposure alters the development of 
the hypothalamic-pituitary-adrenal axis: early illness and later responsivity to stress. J Neurosci 15, 
376-384. 
Shansky, R. M., 2009. Estrogen, stress and the brain: progress toward unraveling gender discrepancies in 
major depressive disorder. Expert Review of Neurotherapeutics 9, 967-973. 
Shansky, R. M., Hamo, C., Hof, P. R., Lou, W., McEwen, B. S., Morrison, J. H., 2010. Estrogen Promotes 
Stress Sensitivity in a Prefrontal Cortex–Amygdala Pathway. Cerebral Cortex 20, 2560-2567. 
Sharon, G., Segal, D., Ringo, J. M., Hefetz, A., Zilber-Rosenberg, I., Rosenberg, E., 2010. Commensal 
bacteria play a role in mating preference of Drosophila melanogaster. Proc Natl Acad Sci U S A 107, 
20051-20056. 
Shen, L., Keenan, M. J., Martin, R. J., Tulley, R. T., Raggio, A. M., McCutcheon, K. L., Zhou, J., 2009. Dietary 
resistant starch increases hypothalamic POMC expression in rats. Obesity (Silver Spring) 17, 40-45. 
Sherwin, E., Dinan, T. G., Cryan, J. F., 2017. Recent developments in understanding the role of the gut 
microbiota in brain health and disease. Ann N Y Acad Sci. 
Singh, P. B., Herbert, J., Roser, B., Arnott, L., Tucker, D. K., Brown, R. E., 1990. Rearing rats in a germ-free 
environment eliminates their odors of individuality. J Chem Ecol 16, 1667-1682. 
Sinha, R., Jastreboff, A. M., 2013. Stress as a common risk factor for obesity and addiction. Biol Psychiatry 
73, 827-835. 
Sirinathsinghji, D. J. S., 1987. Inhibitory influence of corticotropin releasing factor on components of 
sexual behaviour in the male rat. Brain Research 407, 185-190. 
Sivamaruthi, B. S., Madhumita, R., Balamurugan, K., Rajan, K. E., 2015. Cronobacter sakazakii infection 
alters serotonin transporter and improved fear memory retention in the rat. Front Pharmacol 6, 188. 
Smith, J. W., Evans, A. T., Costall, B., Smythe, J. W., 2002. Thyroid hormones, brain function and cognition: 
a brief review. Neuroscience & Biobehavioral Reviews 26, 45-60. 
Smith, S. M., Vale, W. W., 2006a. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine 
responses to stress. Dialogues Clin Neurosci 8, 383-395. 
Smith, S. M., Vale, W. W., 2006b. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine 
responses to stress. Dialogues Clin Neurosci 8, 383-395. 
Smith, S. R., de Jonge, L., Pellymounter, M., Nguyen, T., Harris, R., York, D., Redmann, S., Rood, J., Bray, G. 
A., 2001. Peripheral Administration of Human Corticotropin-Releasing Hormone: A Novel Method to 
Increase Energy Expenditure and Fat Oxidation in Man1. The Journal of Clinical Endocrinology & 
Metabolism 86, 1991-1998. 
So, P. W., Yu, W. S., Kuo, Y. T., Wasserfall, C., Goldstone, A. P., Bell, J. D., Frost, G., 2007. Impact of 




Stephens, M. A. C., Wand, G., 2012. Stress and the HPA Axis: Role of Glucocorticoids in Alcohol 
Dependence. Alcohol Res 34, 468-483. 
Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., Cryan, J. F., 2016. The 
neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem 
Int 99, 110-132. 
Striepens, N., Kendrick, K. M., Maier, W., Hurlemann, R., 2011. Prosocial effects of oxytocin and clinical 
evidence for its therapeutic potential. Frontiers in Neuroendocrinology 32, 426-450. 
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., Kubo, C., Koga, Y., 2004. Postnatal microbial 
colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J 
Physiol 558, 263-275. 
Swartz, T. D., Duca, F. A., de Wouters, T., Sakar, Y., Covasa, M., 2012. Up-regulation of intestinal type 1 
taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake 
in mice lacking gut microbiota. Br J Nutr 107, 621-630. 
Sylvers, P., Lilienfeld, S. O., LaPrairie, J. L., 2011. Differences between trait fear and trait anxiety: 
Implications for psychopathology. Clinical Psychology Review 31, 122-137. 
Szabo, S., Yoshida, M., Filakovszky, J., Juhasz, G., 2017. "Stress" is 80 Years Old: From Hans Selye Original 
Paper in 1936 to Recent Advances in GI Ulceration. Curr Pharm Des 23, 4029-4041. 
Takanaga, H., Ohtsuki, S., Hosoya, K., Terasaki, T., 2001. GAT2/BGT-1 as a system responsible for the 
transport of gamma-aminobutyric acid at the mouse blood-brain barrier. J Cereb Blood Flow Metab 
21, 1232-1239. 
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., Macia, L., 2014. The role of short-chain 
fatty acids in health and disease. Adv Immunol 121, 91-119. 
Tannock, G. W., Savage, D. C., 1974. Influences of dietary and environmental stress on microbial 
populations in the murine gastrointestinal tract. Infect Immun 9, 591-598. 
Tarini, J., Wolever, T. M., 2010. The fermentable fibre inulin increases postprandial serum short-chain 
fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35, 
9-16. 
Tarr, A. J., Galley, J. D., Fisher, S. E., Chichlowski, M., Berg, B. M., Bailey, M. T., 2015. The prebiotics 
3'Sialyllactose and 6'Sialyllactose diminish stressor-induced anxiety-like behavior and colonic 
microbiota alterations: Evidence for effects on the gut-brain axis. Brain Behav Immun 50, 166-177. 
Taylor, S. E., Saphire-Bernstein, S., Seeman, T. E., 2010. Are plasma oxytocin in women and plasma 
vasopressin in men biomarkers of distressed pair-bond relationships? Psychol Sci 21, 3-7. 
Thaiss, C. A., Itav, S., Rothschild, D., Meijer, M. T., Levy, M., Moresi, C., Dohnalová, L., Braverman, S., 
Rozin, S., Malitsky, S., Dori-Bachash, M., Kuperman, Y., Biton, I., Gertler, A., Harmelin, A., Shapiro, H., 
Halpern, Z., Aharoni, A., Segal, E., Elinav, E., 2016. Persistent microbiome alterations modulate the 
rate of post-dieting weight regain. Nature 540, 544-551. 
Thaiss, C. A., Zeevi, D., Levy, M., Zilberman-Schapira, G., Suez, J., Tengeler, A. C., Abramson, L., Katz, M. N., 
Korem, T., Zmora, N., Kuperman, Y., Biton, I., Gilad, S., Harmelin, A., Shapiro, H., Halpern, Z., Segal, 
E., Elinav, E., 2014. Transkingdom control of microbiota diurnal oscillations promotes metabolic 
homeostasis. Cell 159, 514-529. 
Theis, K. R., Venkataraman, A., Dycus, J. A., Koonter, K. D., Schmitt-Matzen, E. N., Wagner, A. P., 
Holekamp, K. E., Schmidt, T. M., 2013. Symbiotic bacteria appear to mediate hyena social odors. Proc 
Natl Acad Sci U S A 110, 19832-19837. 
Till, R. E., Beckwith, B. E., 1985. Sentence memory affected by vasopressin analog (DDAVP) in cross-over 
experiment. Peptides 6, 397-402. 
Tochitani, S., Ikeno, T., Ito, T., Sakurai, A., Yamauchi, T., Matsuzaki, H., 2016. Administration of Non-
Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with 
Alterations in Offspring Behavior. PLoS One 11, e0138293. 
Torres-Fuentes, C., Schellekens, H., Dinan, T. G., Cryan, J. F., 2015. A natural solution for obesity: 
bioactives for the prevention and treatment of weight gain. A review. Nutr Neurosci 18, 49-65. 
Torres-Fuentes, C., Schellekens, H., Dinan, T. G., Cryan, J. F., 2017. The microbiota-gut-brain axis in 




Toufexis, D. J., Tesolin, S., Huang, N., Walker, C., 1999. Altered pituitary sensitivity to corticotropin-
releasing factor and arginine vasopressin participates in the stress hyporesponsiveness of lactation 
in the rat. J Neuroendocrinol 11, 757-764. 
Trasande, L., Blustein, J., Liu, M., Corwin, E., Cox, L. M., Blaser, M. J., 2013. Infant antibiotic exposures and 
early-life body mass. Int J Obes (Lond) 37, 16-23. 
Troyer, K., 1984. Microbes, herbivory and the evolution of social behavior. Journal of Theoretical Biology 
106, 157-169. 
Tsigos, C., Chrousos, G. P., 2002a. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. 
J Psychosom Res 53, 865-871. 
Tsigos, C., Chrousos, G. P., 2002b. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and 
stress. J Psychosom Res 53, 865-871. 
Tsigos, C., Papanicolaou D.A., 1997. Dose Effects of Recombinant Human lnterleukin-6 on Pituitary 
Hormone Secretion and Energy Expenditure. Neuroendocrinology 62. 
Tung, J., Barreiro, L. B., Burns, M. B., Grenier, J. C., Lynch, J., Grieneisen, L. E., Altmann, J., Alberts, S. C., 
Blekhman, R., Archie, E. A., 2015. Social networks predict gut microbiome composition in wild 
baboons. eLife 4. 
Tuohy, K. M., Kolida, S., Lustenberger, A. M., Gibson, G. R., 2001. The prebiotic effects of biscuits 
containing partially hydrolysed guar gum and fructo-oligosaccharides--a human volunteer study. Br J 
Nutr 86, 341-348. 
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. 
J., Roe, B. A., Affourtit, J. P., Egholm, M., Henrissat, B., Heath, A. C., Knight, R., Gordon, J. I., 2009a. A 
core gut microbiome in obese and lean twins. Nature 457, 480-484. 
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. 
J., Roe, B. A., Affourtit, J. P., Egholm, M., Henrissat, B., Heath, A. C., Knight, R., Gordon, J. I., 2009b. A 
core gut microbiome in obese and lean twins. Nature 457, 480-484. 
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., Gordon, J. I., 2006. An obesity-
associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031. 
Uehara, Y., Shimizu, H., Ohtani, K., Sato, N., Mori, M., 1998. Hypothalamic corticotropin-releasing 
hormone is a mediator of the anorexigenic effect of leptin. Diabetes 47, 890-893. 
Ussar, S., Griffin, N. W., Bezy, O., Fujisaka, S., Vienberg, S., Softic, S., Deng, L., Bry, L., Gordon, J. I., Kahn, C. 
R., 2015. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition 
to Obesity and Metabolic Syndrome. Cell Metab 22, 516-530. 
Vadakkadath Meethal, S., Atwood, C. S., 2005. The role of hypothalamic-pituitary-gonadal hormones in 
the normal structure and functioning of the brain. Cell Mol Life Sci 62, 257-270. 
Valladares, R., Bojilova, L., Potts, A. H., Cameron, E., Gardner, C., Lorca, G., Gonzalez, C. F., 2013. 
Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels 
in BioBreeding rats. Faseb j 27, 1711-1720. 
Varian, B. J., Poutahidis, T., DiBenedictis, B. T., Levkovich, T., Ibrahim, Y., Didyk, E., Shikhman, L., Cheung, 
H. K., Hardas, A., Ricciardi, C. E., Kolandaivelu, K., Veenema, A. H., Alm, E. J., Erdman, S. E., 2017. 
Microbial lysate upregulates host oxytocin. Brain Behav Immun 61, 36-49. 
Venu, I., Durisko, Z., Xu, J., Dukas, R., 2014. Social attraction mediated by fruit flies' microbiome. J Exp Biol 
217, 1346-1352. 
Viau, V., 2002. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J 
Neuroendocrinol 14, 506-513. 
Volkow, N. D., Baler, R. D., 2015. NOW vs LATER brain circuits: implications for obesity and addiction. 
Trends Neurosci 38, 345-352. 
Volpe, G. E., Ward, H., Mwamburi, M., Dinh, D., Bhalchandra, S., Wanke, C., Kane, A. V., 2014. 
Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, 
and inflammation. J Stud Alcohol Drugs 75, 347-357. 
Walker, W. H., Cheng, J., 2005. FSH and testosterone signaling in Sertoli cells. Reproduction 130, 15-28. 
Wall, R., Cryan, J. F., Ross, R. P., Fitzgerald, G. F., Dinan, T. G., Stanton, C., 2014. Bacterial neuroactive 




Wall, R., Marques, T. M., O'Sullivan, O., Ross, R. P., Shanahan, F., Quigley, E. M., Dinan, T. G., Kiely, B., 
Fitzgerald, G. F., Cotter, P. D., Fouhy, F., Stanton, C., 2012. Contrasting effects of Bifidobacterium 
breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty 
acids and gut microbiota. Am J Clin Nutr 95, 1278-1287. 
Wang, M., Li, M., Wu, S., Lebrilla, C. B., Chapkin, R. S., Ivanov, I., Donovan, S. M., 2015. Fecal microbiota 
composition of breast-fed infants is correlated with human milk oligosaccharides consumed. J 
Pediatr Gastroenterol Nutr 60, 825-833. 
Weinbach, E. C., Levenbook, L., Alling, D. W., 1992. Binding of tricyclic antidepressant drugs to 
trophozoites of giardia lamblia. Comparative Biochemistry and Physiology Part C: Comparative 
Pharmacology 102, 391-396. 
Wermter, A. K., Kamp-Becker, I., Hesse, P., Schulte-Korne, G., Strauch, K., Remschmidt, H., 2010. Evidence 
for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of 
autistic disorders on high-functioning level. Am J Med Genet B Neuropsychiatr Genet 153b, 629-639. 
Whirledge, S., Cidlowski, J. A., 2010. Glucocorticoids, Stress, and Fertility. Minerva endocrinologica 35, 
109-125. 
White BA, P. S., 2013. Endocrine and Reproductive Physiology. Elsevier Health Sciences, Oxford, UK. 
Wibral, M., Dohmen, T., Klingmuller, D., Weber, B., Falk, A., 2012. Testosterone administration reduces 
lying in men. PLoS One 7, e46774. 
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., Siuzdak, G., 2009. 
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc 
Natl Acad Sci U S A 106, 3698-3703. 
Witt, D. M., Insel, T. R., 1994. Increased Fos Expression in Oxytocin Neurons Following Masculine Sexual 
Behavior. J Neuroendocrinol 6, 13-18. 
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y. Y., Keilbaugh, S. A., Bewtra, M., Knights, D., 
Walters, W. A., Knight, R., Sinha, R., Gilroy, E., Gupta, K., Baldassano, R., Nessel, L., Li, H., Bushman, F. 
D., Lewis, J. D., 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 
105-108. 
Yadav, H., Lee, J. H., Lloyd, J., Walter, P., Rane, S. G., 2013. Beneficial metabolic effects of a probiotic via 
butyrate-induced GLP-1 hormone secretion. J Biol Chem 288, 25088-25097. 
Yan, A. W., Fouts, D. E., Brandl, J., Starkel, P., Torralba, M., Schott, E., Tsukamoto, H., Nelson, K. E., 
Brenner, D. A., Schnabl, B., 2011. Enteric dysbiosis associated with a mouse model of alcoholic liver 
disease. Hepatology 53, 96-105. 
Yang, M., Silverman, J. L., Crawley, J. N., 2011. Automated three-chambered social approach task for 
mice. Curr Protoc Neurosci Chapter 8, Unit 8.26. 
Yang, Y., Zheng, X., Wang, Y., Cao, J., Dong, Z., Cai, J., Sui, N., Xu, L., 2004. Stress Enables Synaptic 
Depression in CA1 Synapses by Acute and Chronic Morphine: Possible Mechanisms for 
Corticosterone on Opiate Addiction. The Journal of Neuroscience 24, 2412-2420. 
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., 
Mazmanian, S. K., Hsiao, E. Y., 2015. Indigenous bacteria from the gut microbiota regulate host 
serotonin biosynthesis. Cell 161, 264-276. 
Zarrinpar, A., Chaix, A., Yooseph, S., Panda, S., 2014. Diet and feeding pattern affect the diurnal dynamics 
of the gut microbiome. Cell Metab 20, 1006-1017. 
Zijlmans, M. A., Korpela, K., Riksen-Walraven, J. M., de Vos, W. M., de Weerth, C., 2015. Maternal 
prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology 53, 
233-245. 
Zilberstein, D., Dwyer, D. M., 1984. Antidepressants cause lethal disruption of membrane function in the 
human protozoan parasite Leishmania. Science 226, 977-979. 
Zoeller, R. T., Tan, S. W., Tyl, R. W., 2007. General Background on the Hypothalamic-Pituitary-Thyroid 










 Intestinal microbes are components of the gut-brain axis, the bidirectional pathway 
between the gut and the brain 
 
 The CNS is closely interconnected with the endocrine system to regulate many 
physiological processes in the human body 
 
 The gut microbiota produces compounds of hormonal nature that influence distal sites 
such as the brain 
 
 The gut microbiota interacts with elements of the host neuroendocrine system to 
modify host behaviours 
 
 The following behaviours are examined: stress, eating behaviour, sexual behaviour, 
sociability, cognition and addiction 
 
